CA2724214A1 - Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use - Google Patents
Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use Download PDFInfo
- Publication number
- CA2724214A1 CA2724214A1 CA2724214A CA2724214A CA2724214A1 CA 2724214 A1 CA2724214 A1 CA 2724214A1 CA 2724214 A CA2724214 A CA 2724214A CA 2724214 A CA2724214 A CA 2724214A CA 2724214 A1 CA2724214 A1 CA 2724214A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- alkyloxy
- carbonyl
- oxo
- piperazin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 284
- -1 Alicyclic carboxylic acid derivatives Chemical class 0.000 title claims description 566
- 239000003814 drug Substances 0.000 title description 5
- 101710088194 Dehydrogenase Proteins 0.000 claims abstract description 19
- 102000004190 Enzymes Human genes 0.000 claims abstract description 12
- 108090000790 Enzymes Proteins 0.000 claims abstract description 12
- 208000030159 metabolic disease Diseases 0.000 claims abstract description 9
- 230000006806 disease prevention Effects 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 198
- 125000001424 substituent group Chemical group 0.000 claims description 85
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 84
- 238000000034 method Methods 0.000 claims description 69
- 238000006243 chemical reaction Methods 0.000 claims description 62
- 125000003118 aryl group Chemical group 0.000 claims description 57
- 229910052731 fluorine Inorganic materials 0.000 claims description 52
- 125000004432 carbon atom Chemical group C* 0.000 claims description 50
- 150000003839 salts Chemical class 0.000 claims description 49
- 239000000460 chlorine Substances 0.000 claims description 47
- 239000011737 fluorine Substances 0.000 claims description 47
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 44
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 40
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 39
- 229910052739 hydrogen Inorganic materials 0.000 claims description 37
- 239000001257 hydrogen Substances 0.000 claims description 37
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 32
- 229910052801 chlorine Inorganic materials 0.000 claims description 31
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 28
- 125000001072 heteroaryl group Chemical group 0.000 claims description 27
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 26
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 26
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 26
- 125000000217 alkyl group Chemical group 0.000 claims description 24
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 24
- 125000002619 bicyclic group Chemical group 0.000 claims description 23
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 23
- 229910052757 nitrogen Inorganic materials 0.000 claims description 23
- 125000005605 benzo group Chemical group 0.000 claims description 22
- 229910052794 bromium Inorganic materials 0.000 claims description 22
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 22
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 claims description 20
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 18
- 125000004658 aryl carbonyl amino group Chemical group 0.000 claims description 18
- 229910052799 carbon Inorganic materials 0.000 claims description 17
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 16
- 125000006576 di-(C1-C3-alkyl)-aminocarbonyl group Chemical group 0.000 claims description 16
- 125000006239 protecting group Chemical group 0.000 claims description 16
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 15
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 15
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims description 14
- 125000005418 aryl aryl group Chemical group 0.000 claims description 14
- 125000004657 aryl sulfonyl amino group Chemical group 0.000 claims description 14
- 125000006563 (C1-3) alkylaminocarbonyl group Chemical group 0.000 claims description 13
- 125000006602 (C1-C3) alkylsulfonylamino group Chemical group 0.000 claims description 13
- 125000006698 (C1-C3) dialkylamino group Chemical group 0.000 claims description 13
- 125000004104 aryloxy group Chemical group 0.000 claims description 13
- 230000002265 prevention Effects 0.000 claims description 13
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 12
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 12
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 12
- 125000006597 (C1-C3) alkylcarbonylamino group Chemical group 0.000 claims description 11
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 11
- 150000001412 amines Chemical class 0.000 claims description 11
- 125000006598 aminocarbonylamino group Chemical group 0.000 claims description 11
- 125000001153 fluoro group Chemical group F* 0.000 claims description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims description 11
- 125000004076 pyridyl group Chemical group 0.000 claims description 11
- 125000004122 cyclic group Chemical group 0.000 claims description 10
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims description 10
- 125000002541 furyl group Chemical group 0.000 claims description 10
- 230000002401 inhibitory effect Effects 0.000 claims description 10
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 10
- 125000001544 thienyl group Chemical group 0.000 claims description 10
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 125000006603 (C1-C3) alkylaminosulfonyl group Chemical group 0.000 claims description 8
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 8
- 125000005100 aryl amino carbonyl group Chemical group 0.000 claims description 8
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 8
- 125000001041 indolyl group Chemical group 0.000 claims description 8
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims description 8
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 8
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 8
- 229910052717 sulfur Inorganic materials 0.000 claims description 8
- 125000006594 (C1-C3) alkylsulfony group Chemical group 0.000 claims description 7
- 125000003342 alkenyl group Chemical group 0.000 claims description 7
- 125000000304 alkynyl group Chemical group 0.000 claims description 7
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 7
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims description 7
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 7
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims description 7
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 7
- 125000004455 (C1-C3) alkylthio group Chemical group 0.000 claims description 6
- FIQVXCWAIJJKKB-UHFFFAOYSA-N 6-azabicyclo[3.3.1]nona-1,3,5,7-tetraene Chemical group C1=CC(C2)=NC=CC2=C1 FIQVXCWAIJJKKB-UHFFFAOYSA-N 0.000 claims description 6
- 125000005129 aryl carbonyl group Chemical group 0.000 claims description 6
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims description 6
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims description 5
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 5
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 5
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 5
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 5
- 239000003085 diluting agent Substances 0.000 claims description 5
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 5
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims description 4
- 239000000969 carrier Substances 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 4
- 125000006599 (C1-C3) alkylaminocarbonylamino group Chemical group 0.000 claims description 3
- 125000006595 (C1-C3) alkylsulfinyl group Chemical group 0.000 claims description 3
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims description 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 3
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 3
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000002883 imidazolyl group Chemical group 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 3
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 claims description 3
- 150000007522 mineralic acids Chemical class 0.000 claims description 3
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 235000005985 organic acids Nutrition 0.000 claims description 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 3
- 125000004306 triazinyl group Chemical group 0.000 claims description 3
- 125000001425 triazolyl group Chemical group 0.000 claims description 3
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 claims description 3
- 125000004768 (C1-C4) alkylsulfinyl group Chemical group 0.000 claims description 2
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 2
- 125000000081 (C5-C8) cycloalkenyl group Chemical group 0.000 claims description 2
- 125000005939 1-azabicyclo[2.2.1]heptyl group Chemical group 0.000 claims description 2
- 125000003830 C1- C4 alkylcarbonylamino group Chemical group 0.000 claims description 2
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 claims description 2
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 claims description 2
- 125000000332 coumarinyl group Chemical group O1C(=O)C(=CC2=CC=CC=C12)* 0.000 claims description 2
- 125000000524 functional group Chemical group 0.000 claims description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical group ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims description 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims description 2
- 125000002971 oxazolyl group Chemical group 0.000 claims description 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims description 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims description 2
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 claims description 2
- 125000000335 thiazolyl group Chemical group 0.000 claims description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 18
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 1
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 claims 1
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 abstract description 16
- 230000005764 inhibitory process Effects 0.000 abstract description 5
- 230000000144 pharmacologic effect Effects 0.000 abstract description 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract description 5
- 208000032928 Dyslipidaemia Diseases 0.000 abstract description 4
- 208000008589 Obesity Diseases 0.000 abstract description 4
- 235000020824 obesity Nutrition 0.000 abstract description 4
- 208000017170 Lipid metabolism disease Diseases 0.000 abstract description 3
- 238000001819 mass spectrum Methods 0.000 description 314
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 189
- 239000000243 solution Substances 0.000 description 164
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 159
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 113
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 108
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 106
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 90
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 87
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 82
- 239000002904 solvent Substances 0.000 description 82
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 77
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 75
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 68
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 67
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 62
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 57
- 229940093499 ethyl acetate Drugs 0.000 description 53
- 235000019439 ethyl acetate Nutrition 0.000 description 53
- 230000002829 reductive effect Effects 0.000 description 52
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 51
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 45
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 44
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 44
- 238000004128 high performance liquid chromatography Methods 0.000 description 44
- 239000012071 phase Substances 0.000 description 44
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 43
- 235000002639 sodium chloride Nutrition 0.000 description 41
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 36
- 230000000875 corresponding effect Effects 0.000 description 36
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 36
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 33
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 33
- 239000013543 active substance Substances 0.000 description 33
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 33
- 239000000047 product Substances 0.000 description 33
- 239000002253 acid Substances 0.000 description 32
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 31
- 238000001816 cooling Methods 0.000 description 31
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 31
- 235000019341 magnesium sulphate Nutrition 0.000 description 31
- 239000000284 extract Substances 0.000 description 30
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 27
- 239000012267 brine Substances 0.000 description 26
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 26
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 24
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 24
- 229960000583 acetic acid Drugs 0.000 description 23
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 21
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 20
- 239000003054 catalyst Substances 0.000 description 19
- 230000009467 reduction Effects 0.000 description 19
- 238000006722 reduction reaction Methods 0.000 description 19
- 102000011145 Hydroxysteroid Dehydrogenases Human genes 0.000 description 18
- 108010062875 Hydroxysteroid Dehydrogenases Proteins 0.000 description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- 229910052723 transition metal Inorganic materials 0.000 description 18
- 150000003624 transition metals Chemical class 0.000 description 18
- 239000003153 chemical reaction reagent Substances 0.000 description 17
- 238000004587 chromatography analysis Methods 0.000 description 17
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 16
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 16
- 239000012074 organic phase Substances 0.000 description 16
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 15
- 239000000654 additive Substances 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 15
- 239000000741 silica gel Substances 0.000 description 15
- 229910002027 silica gel Inorganic materials 0.000 description 15
- 239000007858 starting material Substances 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 13
- 239000002585 base Substances 0.000 description 13
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 13
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 13
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 150000001408 amides Chemical class 0.000 description 12
- 125000003277 amino group Chemical group 0.000 description 12
- 230000001174 ascending effect Effects 0.000 description 12
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 12
- 239000000706 filtrate Substances 0.000 description 12
- 238000001914 filtration Methods 0.000 description 12
- 229910000027 potassium carbonate Inorganic materials 0.000 description 12
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 12
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 12
- ACYFXXFDXDVPND-LWVQHAGNSA-N 4-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]cyclohexane-1-carboxylic acid Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCC(C(O)=O)CC1 ACYFXXFDXDVPND-LWVQHAGNSA-N 0.000 description 11
- 239000012298 atmosphere Substances 0.000 description 11
- 238000010992 reflux Methods 0.000 description 11
- 239000012279 sodium borohydride Substances 0.000 description 11
- 229910000033 sodium borohydride Inorganic materials 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 10
- 150000002148 esters Chemical class 0.000 description 10
- 229960000890 hydrocortisone Drugs 0.000 description 10
- 229910052740 iodine Inorganic materials 0.000 description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 239000003826 tablet Substances 0.000 description 10
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 9
- 239000012039 electrophile Substances 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 8
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 229930194542 Keto Natural products 0.000 description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 8
- 150000007513 acids Chemical class 0.000 description 8
- 125000002252 acyl group Chemical group 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 8
- 239000003125 aqueous solvent Substances 0.000 description 8
- 239000002775 capsule Substances 0.000 description 8
- 150000001721 carbon Chemical group 0.000 description 8
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 8
- XMPZTFVPEKAKFH-UHFFFAOYSA-P ceric ammonium nitrate Chemical compound [NH4+].[NH4+].[Ce+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O XMPZTFVPEKAKFH-UHFFFAOYSA-P 0.000 description 8
- 150000002431 hydrogen Chemical group 0.000 description 8
- 125000000468 ketone group Chemical group 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 8
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Chemical compound C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 7
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 125000005842 heteroatom Chemical group 0.000 description 7
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 7
- 239000012038 nucleophile Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 229910052763 palladium Inorganic materials 0.000 description 7
- 235000011181 potassium carbonates Nutrition 0.000 description 7
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 6
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 6
- DMGLUDJTJZXMMG-UHFFFAOYSA-N 3-benzazocine Chemical compound C1=CN=CC=CC2=CC=CC=C21 DMGLUDJTJZXMMG-UHFFFAOYSA-N 0.000 description 6
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- MLURMJPXVMZZBH-PHAJSTNCSA-N [(1R,3R)-3-aminocyclopentyl]-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)[C@@H]1CC[C@@H](N)C1 MLURMJPXVMZZBH-PHAJSTNCSA-N 0.000 description 6
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- 229910052783 alkali metal Inorganic materials 0.000 description 6
- 150000008064 anhydrides Chemical class 0.000 description 6
- 239000005557 antagonist Substances 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 6
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229960004132 diethyl ether Drugs 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 150000002430 hydrocarbons Chemical group 0.000 description 6
- 125000001841 imino group Chemical group [H]N=* 0.000 description 6
- 150000007529 inorganic bases Chemical class 0.000 description 6
- 239000008101 lactose Substances 0.000 description 6
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000006268 reductive amination reaction Methods 0.000 description 6
- 238000007363 ring formation reaction Methods 0.000 description 6
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 6
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 229920002261 Corn starch Polymers 0.000 description 5
- 239000002841 Lewis acid Substances 0.000 description 5
- 239000000556 agonist Substances 0.000 description 5
- 235000011114 ammonium hydroxide Nutrition 0.000 description 5
- 150000001491 aromatic compounds Chemical class 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 5
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 5
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 5
- 239000008120 corn starch Substances 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 5
- 238000006193 diazotization reaction Methods 0.000 description 5
- 125000004311 dioxin-2-yl group Chemical group [H]C1=C([H])OC(*)=C([H])O1 0.000 description 5
- 235000019253 formic acid Nutrition 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- 150000007517 lewis acids Chemical class 0.000 description 5
- 235000019359 magnesium stearate Nutrition 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 229940098779 methanesulfonic acid Drugs 0.000 description 5
- 229910052759 nickel Inorganic materials 0.000 description 5
- 150000007530 organic bases Chemical group 0.000 description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
- 235000015320 potassium carbonate Nutrition 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 229910052703 rhodium Inorganic materials 0.000 description 5
- 239000010948 rhodium Substances 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 4
- HCIFSCJNVBYMKI-CJNGLKHVSA-N 2,2,2-trifluoro-1-[(1S,9R)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]ethanone Chemical compound C1C2=CC=CC=C2[C@]2(C)CCN(C(=O)C(F)(F)F)[C@@]1([H])C2(C)C HCIFSCJNVBYMKI-CJNGLKHVSA-N 0.000 description 4
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 4
- FEJUGLKDZJDVFY-UHFFFAOYSA-N 9-borabicyclo(3.3.1)nonane Chemical compound C1CCC2CCCC1B2 FEJUGLKDZJDVFY-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 4
- 239000012448 Lithium borohydride Substances 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- 125000003282 alkyl amino group Chemical group 0.000 description 4
- 230000029936 alkylation Effects 0.000 description 4
- 238000005804 alkylation reaction Methods 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 239000012300 argon atmosphere Substances 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- 229950005499 carbon tetrachloride Drugs 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 229910017604 nitric acid Inorganic materials 0.000 description 4
- 150000002825 nitriles Chemical class 0.000 description 4
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 4
- 150000003333 secondary alcohols Chemical class 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 4
- 239000000829 suppository Substances 0.000 description 4
- SLRHVVZKZCRPGV-PGRDOPGGSA-N tert-butyl (1R,9S)-4-methoxy-1,5,13,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C1C2=CC(C)=C(OC)C=C2[C@@]2(C)CCN(C(=O)OC(C)(C)C)[C@]1([H])C2(C)C SLRHVVZKZCRPGV-PGRDOPGGSA-N 0.000 description 4
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 4
- 150000007970 thio esters Chemical class 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- 125000005424 tosyloxy group Chemical group S(=O)(=O)(C1=CC=C(C)C=C1)O* 0.000 description 4
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 4
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 4
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 4
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 3
- 229910015900 BF3 Inorganic materials 0.000 description 3
- JYXPQOZUXFHKFL-KFDQFKALSA-N C1CC(C(=O)OC)CCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 Chemical compound C1CC(C(=O)OC)CCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 JYXPQOZUXFHKFL-KFDQFKALSA-N 0.000 description 3
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 208000002249 Diabetes Complications Diseases 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- 239000001828 Gelatine Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 150000001266 acyl halides Chemical class 0.000 description 3
- 230000010933 acylation Effects 0.000 description 3
- 238000005917 acylation reaction Methods 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 239000002333 angiotensin II receptor antagonist Substances 0.000 description 3
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 3
- 125000005604 azodicarboxylate group Chemical group 0.000 description 3
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 3
- 229910000085 borane Inorganic materials 0.000 description 3
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 239000012024 dehydrating agents Substances 0.000 description 3
- 150000008049 diazo compounds Chemical class 0.000 description 3
- NZZFYRREKKOMAT-UHFFFAOYSA-N diiodomethane Chemical compound ICI NZZFYRREKKOMAT-UHFFFAOYSA-N 0.000 description 3
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 239000003862 glucocorticoid Substances 0.000 description 3
- 238000002868 homogeneous time resolved fluorescence Methods 0.000 description 3
- 150000004678 hydrides Chemical class 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 229910052987 metal hydride Inorganic materials 0.000 description 3
- 150000004681 metal hydrides Chemical class 0.000 description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
- 150000003003 phosphines Chemical class 0.000 description 3
- 235000011007 phosphoric acid Nutrition 0.000 description 3
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 3
- 239000011698 potassium fluoride Substances 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 3
- 235000017550 sodium carbonate Nutrition 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000006103 sulfonylation Effects 0.000 description 3
- 238000005694 sulfonylation reaction Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229940037128 systemic glucocorticoids Drugs 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- KYSZNBLHPCOIKW-PGRDOPGGSA-N tert-butyl (1R,9S)-5-methoxy-1,4,13,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C1C2=CC(OC)=C(C)C=C2[C@@]2(C)CCN(C(=O)OC(C)(C)C)[C@]1([H])C2(C)C KYSZNBLHPCOIKW-PGRDOPGGSA-N 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 3
- 239000005051 trimethylchlorosilane Substances 0.000 description 3
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- JJDBWTARNFHORD-VCTAVGKDSA-N (1R,9R,13S)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-4-carbonitrile Chemical compound C1C2=CC=C(C#N)C=C2[C@]2(C)CCN[C@@]1([H])[C@H]2C JJDBWTARNFHORD-VCTAVGKDSA-N 0.000 description 2
- YHESBFAZUUIVNQ-GOEBONIOSA-N (1R,9S)-5-methoxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene Chemical compound C1C2=CC(OC)=CC=C2[C@@]2(C)CCN[C@]1([H])C2(C)C YHESBFAZUUIVNQ-GOEBONIOSA-N 0.000 description 2
- UEMMLTPBNKTSGU-HIFRSBDPSA-N (1S,9R)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-6-ol Chemical compound C1C2=C(O)C=CC=C2[C@@]2(C)C(C)(C)[C@@H]1NCC2 UEMMLTPBNKTSGU-HIFRSBDPSA-N 0.000 description 2
- LNGJOYPCXLOTKL-SYDPRGILSA-N (1r,3s)-cyclopentane-1,3-dicarboxylic acid Chemical compound OC(=O)[C@H]1CC[C@@H](C(O)=O)C1 LNGJOYPCXLOTKL-SYDPRGILSA-N 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- TYOHPBZJDCPPJJ-UHFFFAOYSA-N 1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-5-carbonitrile Chemical compound C1C2=CC(C#N)=CC=C2C2(C)C(C)(C)C1NCC2 TYOHPBZJDCPPJJ-UHFFFAOYSA-N 0.000 description 2
- WRURMVBXOZOHSH-UHFFFAOYSA-N 1,4-dimethyl-6-(2-phenylethyl)-3,6-dihydro-2h-pyridine Chemical compound CN1CCC(C)=CC1CCC1=CC=CC=C1 WRURMVBXOZOHSH-UHFFFAOYSA-N 0.000 description 2
- RNHDAKUGFHSZEV-UHFFFAOYSA-N 1,4-dioxane;hydrate Chemical compound O.C1COCCO1 RNHDAKUGFHSZEV-UHFFFAOYSA-N 0.000 description 2
- LYPHGRPEVJLRIN-CJNGLKHVSA-N 1-[(1S,9R)-4,5-diamino-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]-2,2,2-trifluoroethanone Chemical compound C1C2=CC(N)=C(N)C=C2[C@]2(C)CCN(C(=O)C(F)(F)F)[C@@]1([H])C2(C)C LYPHGRPEVJLRIN-CJNGLKHVSA-N 0.000 description 2
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 2
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 2
- PGMAFMMZLDHMPH-XXLQHYSLSA-N 2,2,2-trifluoro-1-[(1R,9R,13S)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]ethanone Chemical compound C1C2=CC=C(O)C=C2[C@]2(C)CCN(C(=O)C(F)(F)F)[C@@]1([H])[C@H]2C PGMAFMMZLDHMPH-XXLQHYSLSA-N 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 2
- YWNPZGOKUKAABM-UHFFFAOYSA-N 4,5-dihydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene-10-carboxylic acid Chemical compound OC1=CC2=C(CC3N(CCC2(C3(C)C)C)C(=O)O)C=C1O YWNPZGOKUKAABM-UHFFFAOYSA-N 0.000 description 2
- BAHNDLQFFNMREG-KNQAVFIVSA-N 4-[(1S,9R)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene-10-carbonyl]cyclohexan-1-one Chemical compound C([C@]1(C2=CC=CC=C2C[C@@]2(C1(C)C)[H])C)CN2C(=O)C1CCC(=O)CC1 BAHNDLQFFNMREG-KNQAVFIVSA-N 0.000 description 2
- UUHSFPWOUIZRQL-UHFFFAOYSA-M 4-methyl-1-(1-phenylpropan-2-yl)pyridin-1-ium iodide Chemical compound [I-].CC(CC1=CC=CC=C1)[N+]1=CC=C(C=C1)C UUHSFPWOUIZRQL-UHFFFAOYSA-M 0.000 description 2
- WXEJKPRRTYLMLN-UHFFFAOYSA-N 4-methyl-2-(2-phenylethyl)pyridine Chemical compound CC1=CC=NC(CCC=2C=CC=CC=2)=C1 WXEJKPRRTYLMLN-UHFFFAOYSA-N 0.000 description 2
- KYNCWWUJOAPSAP-UHFFFAOYSA-N 4-methyl-2-(2-phenylethynyl)pyridine Chemical compound CC1=CC=NC(C#CC=2C=CC=CC=2)=C1 KYNCWWUJOAPSAP-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- QNLNNVRSNWQGIQ-JUVBMYLISA-N C(C)(C)(C)OC(N[C@@H]1CC[C@@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3O)=O Chemical compound C(C)(C)(C)OC(N[C@@H]1CC[C@@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3O)=O QNLNNVRSNWQGIQ-JUVBMYLISA-N 0.000 description 2
- CKDWPUIZGOQOOM-UHFFFAOYSA-N Carbamyl chloride Chemical compound NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 description 2
- 206010007558 Cardiac failure chronic Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 2
- 102000016267 Leptin Human genes 0.000 description 2
- 108010092277 Leptin Proteins 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 208000001145 Metabolic Syndrome Diseases 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 2
- CDTOTLJPZPQWFP-KNQAVFIVSA-N N1([C@@H]2CC3=C([C@@](CC1)(C)C2(C)C)C=CC=C3OC)C(=O)C1CCCC1 Chemical compound N1([C@@H]2CC3=C([C@@](CC1)(C)C2(C)C)C=CC=C3OC)C(=O)C1CCCC1 CDTOTLJPZPQWFP-KNQAVFIVSA-N 0.000 description 2
- 229910017711 NHRa Inorganic materials 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 102100038831 Peroxisome proliferator-activated receptor alpha Human genes 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- KNASVMJGHKFQPA-UDTBUJMUSA-N [(1R,9R,13R)-10-[(3S)-2,3-dihydro-1,4-benzodioxine-3-carbonyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-yl] trifluoromethanesulfonate Chemical compound C1OC2=CC=CC=C2O[C@@H]1C(=O)N1CC[C@@]2(C)C3=CC(OS(=O)(=O)C(F)(F)F)=CC=C3C[C@@H]1[C@@H]2C KNASVMJGHKFQPA-UDTBUJMUSA-N 0.000 description 2
- BLVZSMPXCIXJFM-HDIHMHJESA-N [(1R,9R,13S)-5-cyano-1,13-dimethyl-10-(2,2,2-trifluoroacetyl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-yl] trifluoromethanesulfonate Chemical compound C1C2=CC(C#N)=C(OS(=O)(=O)C(F)(F)F)C=C2[C@@]2(C)[C@H](C)[C@@H]1N(C(=O)C(F)(F)F)CC2 BLVZSMPXCIXJFM-HDIHMHJESA-N 0.000 description 2
- IPROZYHGYCDYGE-IRLDBZIGSA-N [(1S,9R)-10-benzyl-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-6-yl] trifluoromethanesulfonate Chemical compound C([C@@]1(C)C2=CC=CC(OS(=O)(=O)C(F)(F)F)=C2C[C@@H]2C1(C)C)CN2CC1=CC=CC=C1 IPROZYHGYCDYGE-IRLDBZIGSA-N 0.000 description 2
- IOPABUNSEZOLJP-UHFFFAOYSA-N [3-(carboxymethyl)-5-methoxy-2,3-dihydro-1h-inden-1-yl]azanium;chloride Chemical compound [Cl-].COC1=CC=C2C([NH3+])CC(CC(O)=O)C2=C1 IOPABUNSEZOLJP-UHFFFAOYSA-N 0.000 description 2
- JLZGOIDTGXNIKD-UHFFFAOYSA-N [5-methoxy-3-(2-methoxy-2-oxoethyl)-2,3-dihydro-1h-inden-1-yl]azanium;chloride Chemical compound [Cl-].C1=C(OC)C=C2C(CC(=O)OC)CC([NH3+])C2=C1 JLZGOIDTGXNIKD-UHFFFAOYSA-N 0.000 description 2
- PTKRUDMLGIIORX-ITGWJZMWSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2r,3s,4r,5r)-5-(3-carbamoyl-4h-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate;cyclohexanamine Chemical compound NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 PTKRUDMLGIIORX-ITGWJZMWSA-N 0.000 description 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- 239000003377 acid catalyst Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 description 2
- 150000001345 alkine derivatives Chemical group 0.000 description 2
- 125000005336 allyloxy group Chemical group 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 238000010640 amide synthesis reaction Methods 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 229940030600 antihypertensive agent Drugs 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 150000001543 aryl boronic acids Chemical class 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 2
- 239000000292 calcium oxide Substances 0.000 description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 2
- 235000013877 carbamide Nutrition 0.000 description 2
- OBZHEBDUNPOCJG-SZTGPWMUSA-N carbenoxolone Chemical compound C([C@H]1C2=CC(=O)[C@@H]34)[C@](C)(C(O)=O)CC[C@@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@H]1[C@@]3(C)CC[C@@H](OC(=O)CCC(O)=O)C1(C)C OBZHEBDUNPOCJG-SZTGPWMUSA-N 0.000 description 2
- 229960000530 carbenoxolone Drugs 0.000 description 2
- 150000001733 carboxylic acid esters Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 150000001879 copper Chemical class 0.000 description 2
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 239000007819 coupling partner Substances 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentanecarboxylic acid Chemical compound OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 description 2
- XOVJAYNMQDTIJD-UHFFFAOYSA-N cyclopentobarbital Chemical compound C1CC=CC1C1(CC=C)C(=O)NC(=O)NC1=O XOVJAYNMQDTIJD-UHFFFAOYSA-N 0.000 description 2
- NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical compound C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 description 2
- WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 2
- KVBKAPANDHPRDG-UHFFFAOYSA-N dibromotetrafluoroethane Chemical compound FC(F)(Br)C(F)(F)Br KVBKAPANDHPRDG-UHFFFAOYSA-N 0.000 description 2
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 229940030606 diuretics Drugs 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 238000007336 electrophilic substitution reaction Methods 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- VTILISUSKRNUQD-RDGATRHJSA-N ethyl (1S,9R)-10-benzyl-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene-6-carboxylate Chemical compound N1([C@@H]2CC3=C([C@@](CC1)(C)C2(C)C)C=CC=C3C(=O)OCC)CC1=CC=CC=C1 VTILISUSKRNUQD-RDGATRHJSA-N 0.000 description 2
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 2
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 description 2
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000008348 humoral response Effects 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 150000002576 ketones Chemical group 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 2
- 229940039781 leptin Drugs 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 150000002680 magnesium Chemical class 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- GVWISOJSERXQBM-UHFFFAOYSA-N n-methylpropan-1-amine Chemical compound CCCNC GVWISOJSERXQBM-UHFFFAOYSA-N 0.000 description 2
- XHFGWHUWQXTGAT-UHFFFAOYSA-N n-methylpropan-2-amine Chemical compound CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 230000009935 nitrosation Effects 0.000 description 2
- 238000007034 nitrosation reaction Methods 0.000 description 2
- 150000002905 orthoesters Chemical class 0.000 description 2
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 2
- 150000003891 oxalate salts Chemical class 0.000 description 2
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 2
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 description 2
- 229960003424 phenylacetic acid Drugs 0.000 description 2
- 239000003279 phenylacetic acid Substances 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- AQSJGOWTSHOLKH-UHFFFAOYSA-N phosphite(3-) Chemical class [O-]P([O-])[O-] AQSJGOWTSHOLKH-UHFFFAOYSA-N 0.000 description 2
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 description 2
- 125000004574 piperidin-2-yl group Chemical group N1C(CCCC1)* 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229910003446 platinum oxide Inorganic materials 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- 235000003270 potassium fluoride Nutrition 0.000 description 2
- 150000003138 primary alcohols Chemical class 0.000 description 2
- UFUASNAHBMBJIX-UHFFFAOYSA-N propan-1-one Chemical compound CC[C]=O UFUASNAHBMBJIX-UHFFFAOYSA-N 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- JQRYUMGHOUYJFW-UHFFFAOYSA-N pyridine;trihydrobromide Chemical compound [Br-].[Br-].[Br-].C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1 JQRYUMGHOUYJFW-UHFFFAOYSA-N 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 238000005932 reductive alkylation reaction Methods 0.000 description 2
- 150000004756 silanes Chemical class 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- KXCAEQNNTZANTK-UHFFFAOYSA-N stannane Chemical compound [SnH4] KXCAEQNNTZANTK-UHFFFAOYSA-N 0.000 description 2
- 229910000080 stannane Inorganic materials 0.000 description 2
- RMMXLENWKUUMAY-UHFFFAOYSA-N telmisartan Chemical compound CCCC1=NC2=C(C)C=C(C=3N(C4=CC=CC=C4N=3)C)C=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C(O)=O RMMXLENWKUUMAY-UHFFFAOYSA-N 0.000 description 2
- SLRHVVZKZCRPGV-GCJKJVERSA-N tert-butyl (1S,9R)-4-methoxy-1,5,13,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C1C2=CC(C)=C(OC)C=C2[C@]2(C)CCN(C(=O)OC(C)(C)C)[C@@]1([H])C2(C)C SLRHVVZKZCRPGV-GCJKJVERSA-N 0.000 description 2
- KYSZNBLHPCOIKW-GCJKJVERSA-N tert-butyl (1S,9R)-5-methoxy-1,4,13,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C1C2=CC(OC)=C(C)C=C2[C@]2(C)CCN(C(=O)OC(C)(C)C)[C@@]1([H])C2(C)C KYSZNBLHPCOIKW-GCJKJVERSA-N 0.000 description 2
- GAQRKXTYMOVDAB-UHFFFAOYSA-N tert-butyl 5-hydroxy-4-methoxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene-10-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC2(C)C(C=C(C(=C3)O)OC)=C3CC1C2(C)C GAQRKXTYMOVDAB-UHFFFAOYSA-N 0.000 description 2
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 150000003509 tertiary alcohols Chemical class 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- 125000003396 thiol group Chemical class [H]S* 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 2
- PBIMIGNDTBRRPI-UHFFFAOYSA-N trifluoro borate Chemical compound FOB(OF)OF PBIMIGNDTBRRPI-UHFFFAOYSA-N 0.000 description 2
- MVJKXJPDBTXECY-UHFFFAOYSA-N trifluoroborane;hydrate Chemical compound O.FB(F)F MVJKXJPDBTXECY-UHFFFAOYSA-N 0.000 description 2
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 2
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 2
- BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 description 2
- 150000003672 ureas Chemical class 0.000 description 2
- 229940075966 (+)- menthol Drugs 0.000 description 1
- NOOLISFMXDJSKH-AEJSXWLSSA-N (+)-menthol Chemical compound CC(C)[C@H]1CC[C@H](C)C[C@@H]1O NOOLISFMXDJSKH-AEJSXWLSSA-N 0.000 description 1
- ACYVWTGOBWQLAK-PGJXCGDNSA-N (1-benzoylpiperidin-2-yl)-[(1S,9R)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCCCN1C(=O)C1=CC=CC=C1 ACYVWTGOBWQLAK-PGJXCGDNSA-N 0.000 description 1
- CLJIBDNZJRFDPO-YDKINWPYSA-N (1-benzoylpiperidin-2-yl)-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCCCN1C(=O)C1=CC=CC=C1 CLJIBDNZJRFDPO-YDKINWPYSA-N 0.000 description 1
- OXIBOJSACGTDFS-YXOHZDMOSA-N (1-benzoylpiperidin-3-yl)-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C(C1)CCCN1C(=O)C1=CC=CC=C1 OXIBOJSACGTDFS-YXOHZDMOSA-N 0.000 description 1
- GLDIIECFBFXLIC-RVOMLKAUSA-N (1-benzylpiperidin-3-yl)-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C(C1)CCCN1CC1=CC=CC=C1 GLDIIECFBFXLIC-RVOMLKAUSA-N 0.000 description 1
- GYSMIUJIRNPYBU-GSLKOEPASA-N (1-benzylpyrrolidin-3-yl)-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C(C1)CCN1CC1=CC=CC=C1 GYSMIUJIRNPYBU-GSLKOEPASA-N 0.000 description 1
- CUOAFHFZRWIVJY-DDHOLCJHSA-N (1R,12R,16S)-1,16-dimethyl-5,7,13-triazatetracyclo[10.3.1.02,10.04,8]hexadeca-2,4(8),5,9-tetraene Chemical compound C1C2=CC=3NC=NC=3C=C2[C@@]2(C)[C@H](C)[C@@H]1NCC2 CUOAFHFZRWIVJY-DDHOLCJHSA-N 0.000 description 1
- SZHKMPFXDXWNBB-MRCXROJRSA-N (1R,9R,13R)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-6-ol Chemical compound C1C2=C(O)C=CC=C2[C@@]2(C)[C@@H](C)[C@@H]1NCC2 SZHKMPFXDXWNBB-MRCXROJRSA-N 0.000 description 1
- HNWSIZLNIDIQNI-COLVAYQJSA-N (1R,9R,13R)-4-methoxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene Chemical compound C1C2=CC=C(OC)C=C2[C@]2(C)CCN[C@@]1([H])[C@@H]2C HNWSIZLNIDIQNI-COLVAYQJSA-N 0.000 description 1
- DPPWIGMPWPZCHP-XXLQHYSLSA-N (1R,9R,13S)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene-5-carbonitrile Chemical compound C1C2=CC(C#N)=C(O)C=C2[C@]2(C)CCN[C@@]1([H])[C@H]2C DPPWIGMPWPZCHP-XXLQHYSLSA-N 0.000 description 1
- JNSJUMZOWGNQBP-DOTOQJQBSA-N (1R,9S)-4-methoxy-1,5,13,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene Chemical compound C1C2=CC(C)=C(OC)C=C2[C@@]2(C)CCN[C@]1([H])C2(C)C JNSJUMZOWGNQBP-DOTOQJQBSA-N 0.000 description 1
- KFRXTMPXHUOPLQ-DOTOQJQBSA-N (1R,9S)-5-methoxy-1,4,13,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene Chemical compound C1C2=CC(OC)=C(C)C=C2[C@@]2(C)CCN[C@]1([H])C2(C)C KFRXTMPXHUOPLQ-DOTOQJQBSA-N 0.000 description 1
- VILHKQOZZFYNMR-MJGOQNOKSA-N (1S,13R)-1,6,7,17,17-pentamethyl-5,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene Chemical compound CC1=C(C)N=C2C=C([C@@]3(CCN[C@@]([H])(C3(C)C)C3)C)C3=CC2=N1 VILHKQOZZFYNMR-MJGOQNOKSA-N 0.000 description 1
- ZTJAZCCRAFXSOO-XELASAAXSA-N (1S,4R)-1-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]-4,7,7-trimethyl-2-oxabicyclo[2.2.1]heptan-3-one Chemical compound C1([C@](C2(C)C)(C)CC3)=CC=CC(O)=C1C[C@H]2N3C(=O)[C@]1(OC2=O)CC[C@]2(C)C1(C)C ZTJAZCCRAFXSOO-XELASAAXSA-N 0.000 description 1
- UEPNLBACUPUIFK-CJNGLKHVSA-N (1S,9R)-1,13,13-trimethyl-10-(2,2,2-trifluoroacetyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-4-sulfonyl chloride Chemical compound C1C2=CC=C(S(Cl)(=O)=O)C=C2[C@]2(C)CCN(C(=O)C(F)(F)F)[C@@]1([H])C2(C)C UEPNLBACUPUIFK-CJNGLKHVSA-N 0.000 description 1
- OFCRGHLUMGFXHN-CJNGLKHVSA-N (1S,9R)-1,13,13-trimethyl-10-(2,2,2-trifluoroacetyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-5-sulfonyl chloride Chemical compound C1C2=CC(S(Cl)(=O)=O)=CC=C2[C@]2(C)CCN(C(=O)C(F)(F)F)[C@@]1([H])C2(C)C OFCRGHLUMGFXHN-CJNGLKHVSA-N 0.000 description 1
- JHMGAVHMUHHKPO-HIFRSBDPSA-N (1S,9R)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-5-ol Chemical compound C1C2=CC(O)=CC=C2[C@]2(C)CCN[C@@]1([H])C2(C)C JHMGAVHMUHHKPO-HIFRSBDPSA-N 0.000 description 1
- HNPZSLGLGWKHSF-HIFRSBDPSA-N (1S,9R)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-6-amine Chemical compound C1C2=C(N)C=CC=C2[C@@]2(C)C(C)(C)[C@@H]1NCC2 HNPZSLGLGWKHSF-HIFRSBDPSA-N 0.000 description 1
- YUWNHQHUEBKGOY-HIFRSBDPSA-N (1S,9R)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene Chemical compound C1C2=CC=CC=C2[C@]2(C)CCN[C@@]1([H])C2(C)C YUWNHQHUEBKGOY-HIFRSBDPSA-N 0.000 description 1
- AIZKTINCTAPRDS-PNIKTXALSA-N (1S,9R)-10-(4-methoxycyclohexanecarbonyl)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene-6-carbonitrile Chemical compound C1CC(OC)CCC1C(=O)N1[C@@H](C2(C)C)CC3=C(C#N)C=CC=C3[C@]2(C)CC1 AIZKTINCTAPRDS-PNIKTXALSA-N 0.000 description 1
- JNSJUMZOWGNQBP-WBVHZDCISA-N (1S,9R)-4-methoxy-1,5,13,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene Chemical compound C1C2=CC(C)=C(OC)C=C2[C@]2(C)CCN[C@@]1([H])C2(C)C JNSJUMZOWGNQBP-WBVHZDCISA-N 0.000 description 1
- YHESBFAZUUIVNQ-ZBFHGGJFSA-N (1S,9R)-5-methoxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene Chemical compound C1C2=CC(OC)=CC=C2[C@]2(C)CCN[C@@]1([H])C2(C)C YHESBFAZUUIVNQ-ZBFHGGJFSA-N 0.000 description 1
- KFRXTMPXHUOPLQ-WBVHZDCISA-N (1S,9R)-5-methoxy-1,4,13,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene Chemical compound C1C2=CC(OC)=C(C)C=C2[C@]2(C)CCN[C@@]1([H])C2(C)C KFRXTMPXHUOPLQ-WBVHZDCISA-N 0.000 description 1
- ASUXUEGHLWKPGH-ZBFHGGJFSA-N (1S,9R)-6-methoxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene Chemical compound N([C@@H](C1(C)C)C2)CC[C@@]1(C)C1=C2C(OC)=CC=C1 ASUXUEGHLWKPGH-ZBFHGGJFSA-N 0.000 description 1
- BVAFVDRKEMUUAD-WBVHZDCISA-N (1S,9R)-N,N,1,13,13-pentamethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-5-sulfonamide Chemical compound C1C2=CC(S(=O)(=O)N(C)C)=CC=C2[C@]2(C)CCN[C@@]1([H])C2(C)C BVAFVDRKEMUUAD-WBVHZDCISA-N 0.000 description 1
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 1
- IRHSQRVCSDPEQL-UHFFFAOYSA-N (2-benzyl-3-oxo-2-azabicyclo[3.3.1]nonan-6-yl) acetate Chemical compound CC(=O)OC1CCC2CC1CC(=O)N2CC1=CC=CC=C1 IRHSQRVCSDPEQL-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- GDRAEFIYNHDTBL-JXJWYLRMSA-N (3-hydroxy-1-adamantyl)-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C1C(C2)CC(C3)CC2(O)CC13C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C GDRAEFIYNHDTBL-JXJWYLRMSA-N 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- HMBHAQMOBKLWRX-QMMMGPOBSA-N (3s)-2,3-dihydro-1,4-benzodioxine-3-carboxylic acid Chemical compound C1=CC=C2O[C@H](C(=O)O)COC2=C1 HMBHAQMOBKLWRX-QMMMGPOBSA-N 0.000 description 1
- ODVKBGOJBJPSNH-NQIIRXRSSA-N (4,4-difluorocyclohexyl)-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCC(F)(F)CC1 ODVKBGOJBJPSNH-NQIIRXRSSA-N 0.000 description 1
- YRLWVBXMUIOXMW-UHFFFAOYSA-N (4,5-dimethoxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl)-(4-methoxycyclohexyl)methanone Chemical compound C1CC(OC)CCC1C(=O)N1C(C2(C)C)CC3=CC(OC)=C(OC)C=C3C2(C)CC1 YRLWVBXMUIOXMW-UHFFFAOYSA-N 0.000 description 1
- NJAPLYYWRORUCD-UHFFFAOYSA-N (4-fluoro-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl)-(4-methoxycyclohexyl)methanone Chemical compound C1CC(OC)CCC1C(=O)N1C(C2(C)C)CC3=CC=C(F)C=C3C2(C)CC1 NJAPLYYWRORUCD-UHFFFAOYSA-N 0.000 description 1
- XADYITLBCVNJHE-VXPHMXNRSA-N (4-hydroxy-1-bicyclo[2.2.2]octanyl)-[(1S,9R)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]methanone Chemical compound C1CC(O)(CC2)CCC12C(=O)N1CC[C@@]2(C)C3=CC=CC=C3C[C@@H]1C2(C)C XADYITLBCVNJHE-VXPHMXNRSA-N 0.000 description 1
- CSSHMFRERHBOMC-UHFFFAOYSA-N (4-hydroxy-5-methoxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl)-(4-methoxycyclohexyl)methanone Chemical compound C1CC(OC)CCC1C(=O)N1C(C2(C)C)CC3=CC(OC)=C(O)C=C3C2(C)CC1 CSSHMFRERHBOMC-UHFFFAOYSA-N 0.000 description 1
- HEJMGNKXKSURAG-UHFFFAOYSA-N (4-methoxycyclohexyl)-(1,13,13-trimethyl-5-phenyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl)methanone Chemical compound C1CC(OC)CCC1C(=O)N1C(C2(C)C)CC3=CC(C=4C=CC=CC=4)=CC=C3C2(C)CC1 HEJMGNKXKSURAG-UHFFFAOYSA-N 0.000 description 1
- RODOCBUEIBXASL-UHFFFAOYSA-N (4-methoxycyclohexyl)-(1,16,16-trimethyl-5,7-dioxa-13-azatetracyclo[10.3.1.02,10.04,8]hexadeca-2,4(8),9-trien-13-yl)methanone Chemical compound C1CC(OC)CCC1C(=O)N1C(C2(C)C)CC3=CC(OCO4)=C4C=C3C2(C)CC1 RODOCBUEIBXASL-UHFFFAOYSA-N 0.000 description 1
- YQAXNMLYNDWSAD-UHFFFAOYSA-N (4-methoxycyclohexyl)-(6-methoxy-13,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl)methanone Chemical compound C1CC(OC)CCC1C(=O)N1C(C2(C)C)CC3=C(OC)C=CC=C3C2CC1 YQAXNMLYNDWSAD-UHFFFAOYSA-N 0.000 description 1
- ZRDVFERLLDJCFL-FSGKXZQKSA-N (4-methoxycyclohexyl)-[(1R,9S)-5-methoxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C([C@@]1(C2=CC=C(OC)C=C2C[C@]2(C1(C)C)[H])C)CN2C(=O)C1CCC(OC)CC1 ZRDVFERLLDJCFL-FSGKXZQKSA-N 0.000 description 1
- CJEZKBCRATVSSR-IHPBKIMVSA-N (4-methoxycyclohexyl)-[(1S,12R)-1,5,6,16,16-pentamethyl-5,7,13-triazatetracyclo[10.3.1.02,10.04,8]hexadeca-2,4(8),6,9-tetraen-13-yl]methanone Chemical compound C1CC(OC)CCC1C(=O)N1[C@@H](C2(C)C)CC3=CC(N=C(C)N4C)=C4C=C3[C@]2(C)CC1 CJEZKBCRATVSSR-IHPBKIMVSA-N 0.000 description 1
- JUJTXVFJJWTJQI-UHFFFAOYSA-N (5-amino-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl)-(4-methoxycyclohexyl)methanone Chemical compound C1CC(OC)CCC1C(=O)N1C(C2(C)C)CC3=CC(N)=CC=C3C2(C)CC1 JUJTXVFJJWTJQI-UHFFFAOYSA-N 0.000 description 1
- MAINSBSFUJEJMK-UHFFFAOYSA-N (5-fluoro-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl)-(4-methoxycyclohexyl)methanone Chemical compound C1CC(OC)CCC1C(=O)N1C(C2(C)C)CC3=CC(F)=CC=C3C2(C)CC1 MAINSBSFUJEJMK-UHFFFAOYSA-N 0.000 description 1
- VYNYNARKBJLCRJ-UHFFFAOYSA-N (5-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl)-(4-methoxycyclohexyl)methanone Chemical compound C1CC(OC)CCC1C(=O)N1C(C2(C)C)CC3=CC(O)=CC=C3C2(C)CC1 VYNYNARKBJLCRJ-UHFFFAOYSA-N 0.000 description 1
- HALWWSKHLRYNTP-UHFFFAOYSA-N (5-hydroxy-4-methoxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl)-(4-methoxycyclohexyl)methanone Chemical compound C1CC(OC)CCC1C(=O)N1C(C2(C)C)CC3=CC(O)=C(OC)C=C3C2(C)CC1 HALWWSKHLRYNTP-UHFFFAOYSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- KOZNQICASAWOMX-UHFFFAOYSA-N 1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-5-amine Chemical compound C1C2=CC(N)=CC=C2C2(C)C(C)(C)C1NCC2 KOZNQICASAWOMX-UHFFFAOYSA-N 0.000 description 1
- JHMGAVHMUHHKPO-UHFFFAOYSA-N 1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-5-ol Chemical compound C1C2=CC(O)=CC=C2C2(C)C(C)(C)C1NCC2 JHMGAVHMUHHKPO-UHFFFAOYSA-N 0.000 description 1
- LVIKMEHNEOMZFQ-UHFFFAOYSA-N 1,16,16-trimethyl-5,7-dioxa-13-azatetracyclo[10.3.1.02,10.04,8]hexadeca-2,4(8),9-triene Chemical compound C1C2=CC=3OCOC=3C=C2C2(C)C(C)(C)C1NCC2 LVIKMEHNEOMZFQ-UHFFFAOYSA-N 0.000 description 1
- VMCPDLVIONHYHV-UHFFFAOYSA-N 1,16,16-trimethyl-5,7-dioxa-13-azatetracyclo[10.3.1.02,10.04,8]hexadeca-2,4(8),9-triene-13-carboxylic acid Chemical compound C1OC2=CC3=C(CC4N(CCC3(C4(C)C)C)C(=O)O)C=C2O1 VMCPDLVIONHYHV-UHFFFAOYSA-N 0.000 description 1
- HHBCEKAWSILOOP-UHFFFAOYSA-N 1,3-dibromo-1,3,5-triazinane-2,4,6-trione Chemical compound BrN1C(=O)NC(=O)N(Br)C1=O HHBCEKAWSILOOP-UHFFFAOYSA-N 0.000 description 1
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- FZDDJYGGPUCDLX-UHFFFAOYSA-N 1,4-dimethyl-2-(2-phenylethyl)-3,6-dihydro-2h-pyridine Chemical compound CN1CC=C(C)CC1CCC1=CC=CC=C1 FZDDJYGGPUCDLX-UHFFFAOYSA-N 0.000 description 1
- 125000005940 1,4-dioxanyl group Chemical group 0.000 description 1
- UWGBMGVOMVXPCG-JSVDNDDVSA-N 1-[(1R,9R,13S)-4-(benzylamino)-1,13-dimethyl-5-nitro-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]-2,2,2-trifluoroethanone Chemical compound C([C@]1(N(CC[C@@](C)(C2=C3)[C@@H]1C)C(=O)C(F)(F)F)[H])C2=CC([N+]([O-])=O)=C3NCC1=CC=CC=C1 UWGBMGVOMVXPCG-JSVDNDDVSA-N 0.000 description 1
- DUKHTEQOZKBSSA-AOAMOSOWSA-N 1-[(1R,9R,13S)-5-bromo-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]-2,2,2-trifluoroethanone Chemical compound C1C2=CC(Br)=C(O)C=C2[C@]2(C)CCN(C(=O)C(F)(F)F)[C@@]1([H])[C@H]2C DUKHTEQOZKBSSA-AOAMOSOWSA-N 0.000 description 1
- MNUWZHVLSIXXEZ-QAPCUYQASA-N 1-[(1S,9R)-4-acetyl-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-2,2,2-trifluoroethanone Chemical compound C1C2=CC=C(C(C)=O)C=C2[C@]2(C)CCN(C(=O)C(F)(F)F)[C@@]1([H])C2(C)C MNUWZHVLSIXXEZ-QAPCUYQASA-N 0.000 description 1
- PRGXIUOJGJRJQA-CJNGLKHVSA-N 1-[(1S,9R)-4-bromo-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-2,2,2-trifluoroethanone Chemical compound C1C2=CC=C(Br)C=C2[C@]2(C)CCN(C(=O)C(F)(F)F)[C@@]1([H])C2(C)C PRGXIUOJGJRJQA-CJNGLKHVSA-N 0.000 description 1
- LYRDVFOLLRFEPF-QAPCUYQASA-N 1-[(1S,9R)-5-acetyl-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-2,2,2-trifluoroethanone Chemical compound C1C2=CC(C(C)=O)=CC=C2[C@]2(C)CCN(C(=O)C(F)(F)F)[C@@]1([H])C2(C)C LYRDVFOLLRFEPF-QAPCUYQASA-N 0.000 description 1
- IRGFZOISHZVQAW-RLOJFFRMSA-N 1-[2-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]piperidin-1-yl]butan-1-one Chemical compound CCCC(=O)N1CCCCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 IRGFZOISHZVQAW-RLOJFFRMSA-N 0.000 description 1
- KPWBSHKAHVMBMD-BTNBVRMJSA-N 1-[2-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]piperidin-1-yl]propan-1-one Chemical compound CCC(=O)N1CCCCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 KPWBSHKAHVMBMD-BTNBVRMJSA-N 0.000 description 1
- GKUCRACIHDPJHE-BTNBVRMJSA-N 1-[2-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]pyrrolidin-1-yl]butan-1-one Chemical compound CCCC(=O)N1CCCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 GKUCRACIHDPJHE-BTNBVRMJSA-N 0.000 description 1
- UMLHZZQBLIVFRT-BIVZGKPNSA-N 1-[2-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]pyrrolidin-1-yl]ethanone Chemical compound CC(=O)N1CCCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 UMLHZZQBLIVFRT-BIVZGKPNSA-N 0.000 description 1
- OWCBMJYTEYFYBS-PNYWAOBFSA-N 1-[2-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]pyrrolidin-1-yl]propan-1-one Chemical compound CCC(=O)N1CCCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 OWCBMJYTEYFYBS-PNYWAOBFSA-N 0.000 description 1
- FJPHWIDQZXHYGB-DZHRLERZSA-N 1-[3-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]pyrrolidin-1-yl]butan-1-one Chemical compound C1N(C(=O)CCC)CCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 FJPHWIDQZXHYGB-DZHRLERZSA-N 0.000 description 1
- ZEIXYSKQHZUPPW-FMUUIRHUSA-N 1-adamantyl-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C1C(C2)CC(C3)CC2CC13C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C ZEIXYSKQHZUPPW-FMUUIRHUSA-N 0.000 description 1
- HWJZREMJMSSZCC-ODBRLQTDSA-N 1-benzyl-4-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]pyrrolidin-2-one Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C(CC1=O)CN1CC1=CC=CC=C1 HWJZREMJMSSZCC-ODBRLQTDSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- BKSWTQTWKNVODB-XUBVMNHFSA-N 1-cyclopentyl-4-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]pyrrolidin-2-one Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C(CC1=O)CN1C1CCCC1 BKSWTQTWKNVODB-XUBVMNHFSA-N 0.000 description 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- 125000006039 1-hexenyl group Chemical group 0.000 description 1
- FPIRBHDGWMWJEP-UHFFFAOYSA-N 1-hydroxy-7-azabenzotriazole Chemical compound C1=CN=C2N(O)N=NC2=C1 FPIRBHDGWMWJEP-UHFFFAOYSA-N 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- WHYASBKVZHKQTN-UHFFFAOYSA-N 1-methylpyrazole-4-sulfonic acid Chemical compound CN1C=C(S(O)(=O)=O)C=N1 WHYASBKVZHKQTN-UHFFFAOYSA-N 0.000 description 1
- 125000006023 1-pentenyl group Chemical group 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- HSVCDLWTQGOHLG-UHFFFAOYSA-N 10-(4-methoxycyclohexanecarbonyl)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-5-carbonitrile Chemical compound C1CC(OC)CCC1C(=O)N1C(C2(C)C)CC3=CC(C#N)=CC=C3C2(C)CC1 HSVCDLWTQGOHLG-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- MOFIILTWICHZMR-UHFFFAOYSA-N 13,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-1-ol Chemical compound C1C2=CC=CC=C2C2(O)C(C)(C)C1NCC2 MOFIILTWICHZMR-UHFFFAOYSA-N 0.000 description 1
- QMNWYGTWTXOQTP-UHFFFAOYSA-N 1h-triazin-6-one Chemical class O=C1C=CN=NN1 QMNWYGTWTXOQTP-UHFFFAOYSA-N 0.000 description 1
- KWKRCOZRQCCMEH-BGFNQPPGSA-N 2,2,2-trifluoro-1-[(1R,9R,13S)-4-hydroxy-1,13-dimethyl-5-nitro-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]ethanone Chemical compound C1C2=CC([N+]([O-])=O)=C(O)C=C2[C@]2(C)CCN(C(=O)C(F)(F)F)[C@@]1([H])[C@H]2C KWKRCOZRQCCMEH-BGFNQPPGSA-N 0.000 description 1
- UNOJKXOPIDFMLN-VYROHLMNSA-N 2,2,2-trifluoro-1-[(1R,9R,13S)-4-methoxy-1,13-dimethyl-5-nitro-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]ethanone Chemical compound C1C2=CC([N+]([O-])=O)=C(OC)C=C2[C@]2(C)CCN(C(=O)C(F)(F)F)[C@@]1([H])[C@H]2C UNOJKXOPIDFMLN-VYROHLMNSA-N 0.000 description 1
- SCYNXAQFQUENNY-CJNGLKHVSA-N 2,2,2-trifluoro-1-[(1S,9R)-1,13,13-trimethyl-4,5-dinitro-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]ethanone Chemical compound C1C2=CC([N+]([O-])=O)=C([N+]([O-])=O)C=C2[C@]2(C)CCN(C(=O)C(F)(F)F)[C@@]1([H])C2(C)C SCYNXAQFQUENNY-CJNGLKHVSA-N 0.000 description 1
- KCYMISIAOCMAPM-PBHICJAKSA-N 2,2,2-trifluoro-1-[(1S,9R)-1,13,13-trimethyl-4-methylsulfonyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]ethanone Chemical compound C1C2=CC=C(S(C)(=O)=O)C=C2[C@]2(C)CCN(C(=O)C(F)(F)F)[C@@]1([H])C2(C)C KCYMISIAOCMAPM-PBHICJAKSA-N 0.000 description 1
- GUMJKGZCNDPNFX-PBHICJAKSA-N 2,2,2-trifluoro-1-[(1S,9R)-1,13,13-trimethyl-6-methylsulfonyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]ethanone Chemical compound C([C@@H]1C([C@@]2(C)CCN1C(=O)C(F)(F)F)(C)C)C1=C2C=CC=C1S(C)(=O)=O GUMJKGZCNDPNFX-PBHICJAKSA-N 0.000 description 1
- XDIPKZPNTYNIIK-CJNGLKHVSA-N 2,2,2-trifluoro-1-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]ethanone Chemical compound C1C2=C(O)C=CC=C2[C@@]2(C)C(C)(C)[C@@H]1N(C(=O)C(F)(F)F)CC2 XDIPKZPNTYNIIK-CJNGLKHVSA-N 0.000 description 1
- FJYZEGXRIHUZKE-WBMJQRKESA-N 2,2,2-trifluoro-1-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-5-nitro-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]ethanone Chemical compound C1C2=C(O)C([N+]([O-])=O)=CC=C2[C@@]2(C)C(C)(C)[C@@H]1N(C(=O)C(F)(F)F)CC2 FJYZEGXRIHUZKE-WBMJQRKESA-N 0.000 description 1
- QZAAOPKOSTWITM-DYVFJYSZSA-N 2,2,2-trifluoro-1-[(1S,9R)-6-methoxy-1,13,13-trimethyl-5-nitro-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]ethanone Chemical compound FC(F)(F)C(=O)N1CC[C@@]2(C)C3=CC=C([N+]([O-])=O)C(OC)=C3C[C@@H]1C2(C)C QZAAOPKOSTWITM-DYVFJYSZSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- XBNGYFFABRKICK-UHFFFAOYSA-N 2,3,4,5,6-pentafluorophenol Chemical compound OC1=C(F)C(F)=C(F)C(F)=C1F XBNGYFFABRKICK-UHFFFAOYSA-N 0.000 description 1
- MBPCLMQATZONBH-QQBDXIIHSA-N 2,3-dihydro-1,4-benzodioxin-3-yl-[(1R,9R)-1-ethyl-4-hydroxy-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound O1C(COC2=C1C=CC=C2)C(=O)N2[C@H]1CC3=C([C@](CC2)(C1)CC)C=C(C=C3)O MBPCLMQATZONBH-QQBDXIIHSA-N 0.000 description 1
- SPBIGLWBLPSTAD-RIWUNNJKSA-N 2,3-dihydro-1,4-benzodioxin-3-yl-[(1R,9R)-1-ethyl-4-methoxy-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C1OC2=CC=CC=C2OC1C(=O)N1CC[C@@]2(CC)C3=CC(OC)=CC=C3C[C@H]1C2 SPBIGLWBLPSTAD-RIWUNNJKSA-N 0.000 description 1
- FITNPEDFWSPOMU-UHFFFAOYSA-N 2,3-dihydrotriazolo[4,5-b]pyridin-5-one Chemical compound OC1=CC=C2NN=NC2=N1 FITNPEDFWSPOMU-UHFFFAOYSA-N 0.000 description 1
- LNSCNEJNLACZPA-UHFFFAOYSA-N 2,3-dihydroxy-2,3-bis(2-methylphenyl)butanedioic acid Chemical compound CC1=CC=CC=C1C(O)(C(O)=O)C(O)(C(O)=O)C1=CC=CC=C1C LNSCNEJNLACZPA-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- QZVGARLXKUKHPA-UHFFFAOYSA-N 2,5-dimethylfuran-3-sulfonic acid Chemical compound CC1=CC(S(O)(=O)=O)=C(C)O1 QZVGARLXKUKHPA-UHFFFAOYSA-N 0.000 description 1
- HKPRDRAWVKBWEF-UHFFFAOYSA-N 2-(3-amino-6-methoxy-2,3-dihydro-1h-inden-1-yl)acetic acid Chemical compound COC1=CC=C2C(N)CC(CC(O)=O)C2=C1 HKPRDRAWVKBWEF-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- VYEGAEUUQMJXTM-UHFFFAOYSA-N 2-(chloromethyl)-1-methylimidazole Chemical compound CN1C=CN=C1CCl VYEGAEUUQMJXTM-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- KMNREWMZOIRBLI-YDKINWPYSA-N 2-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]-N-phenylpiperidine-1-carboxamide Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCCCN1C(=O)NC1=CC=CC=C1 KMNREWMZOIRBLI-YDKINWPYSA-N 0.000 description 1
- BWXLJSOCVKVPBL-UHFFFAOYSA-N 2-[(2-methoxyphenyl)methyl]-3,3-dimethylpiperidin-4-ol Chemical compound COC1=CC=CC=C1CC1C(C)(C)C(O)CCN1 BWXLJSOCVKVPBL-UHFFFAOYSA-N 0.000 description 1
- SFRLBDFHRVVIRX-UHFFFAOYSA-N 2-[(2-methoxyphenyl)methyl]-3,3-dimethylpiperidin-4-one Chemical compound COC1=CC=CC=C1CC1C(C)(C)C(=O)CCN1 SFRLBDFHRVVIRX-UHFFFAOYSA-N 0.000 description 1
- FHEYFIGWYQJVDR-ACJLOTCBSA-N 2-[[3-[(2r)-2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1h-indol-7-yl]oxy]acetic acid Chemical compound C1([C@@H](O)CN[C@@H](CC=2C3=CC=CC(OCC(O)=O)=C3NC=2)C)=CC=CC(Cl)=C1 FHEYFIGWYQJVDR-ACJLOTCBSA-N 0.000 description 1
- PWLUQBOQYYNMBC-BKTOLPLHSA-N 2-adamantyl-[(1S,9R)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]methanone Chemical compound C1C(CC2C3)CC3CC1C2C(=O)N1CC[C@@]2(C)C3=CC=CC=C3C[C@@H]1C2(C)C PWLUQBOQYYNMBC-BKTOLPLHSA-N 0.000 description 1
- DHEOXKYQCRFYRN-FVUBKNNUSA-N 2-adamantyl-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C1C(CC2C3)CC3CC1C2C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C DHEOXKYQCRFYRN-FVUBKNNUSA-N 0.000 description 1
- KMGUEILFFWDGFV-UHFFFAOYSA-N 2-benzoyl-2-benzoyloxy-3-hydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(C(C(O)=O)O)(C(O)=O)OC(=O)C1=CC=CC=C1 KMGUEILFFWDGFV-UHFFFAOYSA-N 0.000 description 1
- PDXXCGKDIOBOCD-NVSUIMDFSA-N 2-bicyclo[2.2.1]heptanyl-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C1C2=C(O)C=CC=C2[C@@]2(C)C(C)(C)[C@@H]1N(C(=O)C1C3CCC(C3)C1)CC2 PDXXCGKDIOBOCD-NVSUIMDFSA-N 0.000 description 1
- XIFZAVDDPZDOGY-MGAPDPFESA-N 2-bicyclo[2.2.2]octanyl-[(1S,9R)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]methanone Chemical compound C1C(CC2)CCC2C1C(=O)N1CC[C@@]2(C)C3=CC=CC=C3C[C@@H]1C2(C)C XIFZAVDDPZDOGY-MGAPDPFESA-N 0.000 description 1
- CVKMHBPGKJDEPZ-JAIUQYDJSA-N 2-bicyclo[2.2.2]octanyl-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C1C(CC2)CCC2C1C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C CVKMHBPGKJDEPZ-JAIUQYDJSA-N 0.000 description 1
- LSZMVESSGLHDJE-UHFFFAOYSA-N 2-bromo-4-methylpyridine Chemical compound CC1=CC=NC(Br)=C1 LSZMVESSGLHDJE-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- JSBBMMHTNIUVTC-UHFFFAOYSA-N 2-hydroxyethanone Chemical group OC[C]=O JSBBMMHTNIUVTC-UHFFFAOYSA-N 0.000 description 1
- MGOLNIXAPIAKFM-UHFFFAOYSA-N 2-isocyanato-2-methylpropane Chemical compound CC(C)(C)N=C=O MGOLNIXAPIAKFM-UHFFFAOYSA-N 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 description 1
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 1
- BQHVJVIMPBBNIX-YZZQRFRASA-N 3,4-dihydro-2H-chromen-2-yl-[(1S,9R)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]methanone Chemical compound C1CC2=CC=CC=C2OC1C(=O)N1CC[C@@]2(C)C3=CC=CC=C3C[C@@H]1C2(C)C BQHVJVIMPBBNIX-YZZQRFRASA-N 0.000 description 1
- XQLQWECSVFMJAS-YZZQRFRASA-N 3,4-dihydro-2H-chromen-2-yl-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C1CC2=CC=CC=C2OC1C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C XQLQWECSVFMJAS-YZZQRFRASA-N 0.000 description 1
- WADSJYLPJPTMLN-UHFFFAOYSA-N 3-(cycloundecen-1-yl)-1,2-diazacycloundec-2-ene Chemical compound C1CCCCCCCCC=C1C1=NNCCCCCCCC1 WADSJYLPJPTMLN-UHFFFAOYSA-N 0.000 description 1
- MPGSDQCLRIPEHC-LWVQHAGNSA-N 3-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]cyclohexane-1-carboxylic acid Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCCC(C(O)=O)C1 MPGSDQCLRIPEHC-LWVQHAGNSA-N 0.000 description 1
- DGQCYFAORCPYHA-GXFFEGLMSA-N 3-[2-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]pyrrolidin-1-yl]propanenitrile Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCCN1CCC#N DGQCYFAORCPYHA-GXFFEGLMSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- 125000006041 3-hexenyl group Chemical group 0.000 description 1
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 239000003148 4 aminobutyric acid receptor blocking agent Substances 0.000 description 1
- UOQQWVPTZGWAPJ-UHFFFAOYSA-N 4,5-dimethoxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene Chemical compound C1C(C2(C)C)NCCC2(C)C2=C1C=C(OC)C(OC)=C2 UOQQWVPTZGWAPJ-UHFFFAOYSA-N 0.000 description 1
- JNZHOKDMZKVPDT-JSIBCLQXSA-N 4-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]-1-phenylpyrrolidin-2-one Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C(CC1=O)CN1C1=CC=CC=C1 JNZHOKDMZKVPDT-JSIBCLQXSA-N 0.000 description 1
- XZAPZFGBONZKGQ-GARHKUQKSA-N 4-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]pyrrolidin-2-one Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CNC(=O)C1 XZAPZFGBONZKGQ-GARHKUQKSA-N 0.000 description 1
- KXMRDHPZQHAXML-UHFFFAOYSA-N 4-[(2-methylpropan-2-yl)oxycarbonylamino]cyclohexane-1-carboxylic acid Chemical compound CC(C)(C)OC(=O)NC1CCC(C(O)=O)CC1 KXMRDHPZQHAXML-UHFFFAOYSA-N 0.000 description 1
- IJTQIFFGXVRWSA-UHFFFAOYSA-N 4-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]cyclohexane-1-carboxylic acid Chemical compound CC(C)(C)OC(=O)N(C)C1CCC(C(O)=O)CC1 IJTQIFFGXVRWSA-UHFFFAOYSA-N 0.000 description 1
- BPMDRYRQUAFZNV-UHFFFAOYSA-N 4-fluoro-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene Chemical compound C1C2=CC=C(F)C=C2C2(C)C(C)(C)C1NCC2 BPMDRYRQUAFZNV-UHFFFAOYSA-N 0.000 description 1
- 125000006042 4-hexenyl group Chemical group 0.000 description 1
- ORGBXLZFLQFFGS-UHFFFAOYSA-N 4-hydroxy-10-(4-methoxycyclohexanecarbonyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-1-carboxylic acid Chemical compound C1CC(OC)CCC1C(=O)N1C(CC=2C3=CC(O)=CC=2)CC3(C(O)=O)CC1 ORGBXLZFLQFFGS-UHFFFAOYSA-N 0.000 description 1
- MEOFWKKXBNHWIE-UHFFFAOYSA-N 4-hydroxy-10-(4-methoxycyclohexanecarbonyl)-N,N-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-1-carboxamide Chemical compound C1CC(OC)CCC1C(=O)N1C(CC=2C3=CC(O)=CC=2)CC3(C(=O)N(C)C)CC1 MEOFWKKXBNHWIE-UHFFFAOYSA-N 0.000 description 1
- BCUVEXJWTHNCOG-UHFFFAOYSA-N 4-methoxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-5-ol Chemical compound N1CCC2(C)C(C=C(C(=C3)O)OC)=C3CC1C2(C)C BCUVEXJWTHNCOG-UHFFFAOYSA-N 0.000 description 1
- MWMITLKZUPSAQS-UHFFFAOYSA-N 4-methoxy-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene Chemical compound C1C2C3=CC(OC)=CC=C3C1NCC2 MWMITLKZUPSAQS-UHFFFAOYSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- 102000006902 5-HT2C Serotonin Receptor Human genes 0.000 description 1
- 108010072553 5-HT2C Serotonin Receptor Proteins 0.000 description 1
- NFFXEUUOMTXWCX-UHFFFAOYSA-N 5-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]-2-methoxy-n-[[4-(trifluoromethyl)phenyl]methyl]benzamide Chemical compound C1=C(C(=O)NCC=2C=CC(=CC=2)C(F)(F)F)C(OC)=CC=C1CC1SC(=O)NC1=O NFFXEUUOMTXWCX-UHFFFAOYSA-N 0.000 description 1
- JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 description 1
- IMVDZFOSXJSXFP-UHFFFAOYSA-N 5-chloro-2-propyl-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carbaldehyde Chemical compound CCCC1=NC(Cl)=C(C=O)N1CC1=CC=C(C=2C(=CC=CC=2)C2=NNN=N2)C=C1 IMVDZFOSXJSXFP-UHFFFAOYSA-N 0.000 description 1
- KEZYDPJUXYLBSQ-UHFFFAOYSA-N 5-fluoro-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene Chemical compound C1C2=CC(F)=CC=C2C2(C)C(C)(C)C1NCC2 KEZYDPJUXYLBSQ-UHFFFAOYSA-N 0.000 description 1
- 125000006043 5-hexenyl group Chemical group 0.000 description 1
- YHESBFAZUUIVNQ-UHFFFAOYSA-N 5-methoxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene Chemical compound N1CCC2(C)C3=CC=C(OC)C=C3CC1C2(C)C YHESBFAZUUIVNQ-UHFFFAOYSA-N 0.000 description 1
- NGONQJQNUKWGKO-UHFFFAOYSA-N 5-methoxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol Chemical compound C1C(C2(C)C)NCCC2(C)C2=C1C=C(OC)C(O)=C2 NGONQJQNUKWGKO-UHFFFAOYSA-N 0.000 description 1
- RVDLHGSZWAELAU-UHFFFAOYSA-N 5-tert-butylthiophene-2-carbonyl chloride Chemical compound CC(C)(C)C1=CC=C(C(Cl)=O)S1 RVDLHGSZWAELAU-UHFFFAOYSA-N 0.000 description 1
- WKJMAHRPSKBGDG-UHFFFAOYSA-N 6-benzyl-6-azabicyclo[3.3.1]nonan-2-ol Chemical compound OC1CCC2CC1CCN2CC1=CC=CC=C1 WKJMAHRPSKBGDG-UHFFFAOYSA-N 0.000 description 1
- CPPSEAIXKLIXAR-UHFFFAOYSA-N 6-benzyl-6-azabicyclo[3.3.1]nonan-2-one Chemical compound O=C1CCC2CC1CCN2CC1=CC=CC=C1 CPPSEAIXKLIXAR-UHFFFAOYSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 101100460776 Arabidopsis thaliana NPY2 gene Proteins 0.000 description 1
- 101100460788 Arabidopsis thaliana NPY5 gene Proteins 0.000 description 1
- 101100515516 Arabidopsis thaliana XI-H gene Proteins 0.000 description 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 1
- PTQXTEKSNBVPQJ-UHFFFAOYSA-N Avasimibe Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1CC(=O)NS(=O)(=O)OC1=C(C(C)C)C=CC=C1C(C)C PTQXTEKSNBVPQJ-UHFFFAOYSA-N 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 239000007848 Bronsted acid Substances 0.000 description 1
- SDOAANGSNRJOHI-ZBFHGGJFSA-N C([C@@H]1C([C@@]2(C)CCN1)(C)C)C1=C2C=CC=C1S(C)(=O)=O Chemical compound C([C@@H]1C([C@@]2(C)CCN1)(C)C)C1=C2C=CC=C1S(C)(=O)=O SDOAANGSNRJOHI-ZBFHGGJFSA-N 0.000 description 1
- AYAYZIDLEHIICU-GGAORHGYSA-N C([C@@]1(C)C2=CC=CC(=C2C[C@@H]2C1(C)C)C#N)CN2CC1=CC=CC=C1 Chemical compound C([C@@]1(C)C2=CC=CC(=C2C[C@@H]2C1(C)C)C#N)CN2CC1=CC=CC=C1 AYAYZIDLEHIICU-GGAORHGYSA-N 0.000 description 1
- ZCIPKHOPMLCIFJ-GGAORHGYSA-N C([C@@]1(C)C2=CC=CC(CO)=C2C[C@@H]2C1(C)C)CN2CC1=CC=CC=C1 Chemical compound C([C@@]1(C)C2=CC=CC(CO)=C2C[C@@H]2C1(C)C)CN2CC1=CC=CC=C1 ZCIPKHOPMLCIFJ-GGAORHGYSA-N 0.000 description 1
- GPYLJMAAKNYNGT-ALIIKZNMSA-N C([C@@]1(C2=CC(=CC=C2C[C@]2(C1(C)C)[H])C(C)=O)C)CN2C(=O)C1CCC(OC)CC1 Chemical compound C([C@@]1(C2=CC(=CC=C2C[C@]2(C1(C)C)[H])C(C)=O)C)CN2C(=O)C1CCC(OC)CC1 GPYLJMAAKNYNGT-ALIIKZNMSA-N 0.000 description 1
- VRVDUHDFGUUHOV-OGUDKMQBSA-N C([C@@]1(C2=CC(=CC=C2C[C@]2(C1(C)C)[H])S(=O)(=O)N(C)C)C)CN2C(=O)C1CCC(OC)CC1 Chemical compound C([C@@]1(C2=CC(=CC=C2C[C@]2(C1(C)C)[H])S(=O)(=O)N(C)C)C)CN2C(=O)C1CCC(OC)CC1 VRVDUHDFGUUHOV-OGUDKMQBSA-N 0.000 description 1
- DWGDIMHGBCUAMN-FSGKXZQKSA-N C([C@@]1(C2=CC(=CC=C2C[C@]2(C1(C)C)[H])S(=O)(=O)NC)C)CN2C(=O)C1CCC(OC)CC1 Chemical compound C([C@@]1(C2=CC(=CC=C2C[C@]2(C1(C)C)[H])S(=O)(=O)NC)C)CN2C(=O)C1CCC(OC)CC1 DWGDIMHGBCUAMN-FSGKXZQKSA-N 0.000 description 1
- OSSOEHZFGSLJBN-FSGKXZQKSA-N C([C@@]1(C2=CC(=CC=C2C[C@]2(C1(C)C)[H])S(C)(=O)=O)C)CN2C(=O)C1CCC(OC)CC1 Chemical compound C([C@@]1(C2=CC(=CC=C2C[C@]2(C1(C)C)[H])S(C)(=O)=O)C)CN2C(=O)C1CCC(OC)CC1 OSSOEHZFGSLJBN-FSGKXZQKSA-N 0.000 description 1
- KDIAIQAXUHQLNX-OGUDKMQBSA-N C([C@@]1(C2=CC(C)=C(OC)C=C2C[C@]2(C1(C)C)[H])C)CN2C(=O)C1CCC(OC)CC1 Chemical compound C([C@@]1(C2=CC(C)=C(OC)C=C2C[C@]2(C1(C)C)[H])C)CN2C(=O)C1CCC(OC)CC1 KDIAIQAXUHQLNX-OGUDKMQBSA-N 0.000 description 1
- JVGJUJGELHIPEI-OGUDKMQBSA-N C([C@@]1(C2=CC(OC)=C(C)C=C2C[C@]2(C1(C)C)[H])C)CN2C(=O)C1CCC(OC)CC1 Chemical compound C([C@@]1(C2=CC(OC)=C(C)C=C2C[C@]2(C1(C)C)[H])C)CN2C(=O)C1CCC(OC)CC1 JVGJUJGELHIPEI-OGUDKMQBSA-N 0.000 description 1
- CKJNFZVZYBKPAZ-NZQKXSOJSA-N C([C@@]1(C2=CC=C(C=C2C[C@]2(C1(C)C)[H])C(C)=O)C)CN2C(=O)N1CCCCC1 Chemical compound C([C@@]1(C2=CC=C(C=C2C[C@]2(C1(C)C)[H])C(C)=O)C)CN2C(=O)N1CCCCC1 CKJNFZVZYBKPAZ-NZQKXSOJSA-N 0.000 description 1
- LOIYNHXLSAUNSK-LZZFGILVSA-N C([C@]1(C2=CC(=CC=C2C[C@@]2([C@H]1C)[H])C(=O)OCC)C)CN2C(=O)C1CCC(OC)CC1 Chemical compound C([C@]1(C2=CC(=CC=C2C[C@@]2([C@H]1C)[H])C(=O)OCC)C)CN2C(=O)C1CCC(OC)CC1 LOIYNHXLSAUNSK-LZZFGILVSA-N 0.000 description 1
- KDIAIQAXUHQLNX-PGDSYLSJSA-N C([C@]1(C2=CC(C)=C(OC)C=C2C[C@@]2(C1(C)C)[H])C)CN2C(=O)C1CCC(OC)CC1 Chemical compound C([C@]1(C2=CC(C)=C(OC)C=C2C[C@@]2(C1(C)C)[H])C)CN2C(=O)C1CCC(OC)CC1 KDIAIQAXUHQLNX-PGDSYLSJSA-N 0.000 description 1
- JVGJUJGELHIPEI-PGDSYLSJSA-N C([C@]1(C2=CC(OC)=C(C)C=C2C[C@@]2(C1(C)C)[H])C)CN2C(=O)C1CCC(OC)CC1 Chemical compound C([C@]1(C2=CC(OC)=C(C)C=C2C[C@@]2(C1(C)C)[H])C)CN2C(=O)C1CCC(OC)CC1 JVGJUJGELHIPEI-PGDSYLSJSA-N 0.000 description 1
- RRUWPBMHVSBSLM-KBNVHSFYSA-N C([C@]1(C2=CC3=NC(C)=C(C)N=C3C=C2C[C@@]2(C1(C)C)[H])C)CN2C(=O)C1CCC(OC)CC1 Chemical compound C([C@]1(C2=CC3=NC(C)=C(C)N=C3C=C2C[C@@]2(C1(C)C)[H])C)CN2C(=O)C1CCC(OC)CC1 RRUWPBMHVSBSLM-KBNVHSFYSA-N 0.000 description 1
- HSVCDLWTQGOHLG-PHUNDQRJSA-N C([C@]1(C2=CC=C(C=C2C[C@@]2(C1(C)C)[H])C#N)C)CN2C(=O)C1CCC(OC)CC1 Chemical compound C([C@]1(C2=CC=C(C=C2C[C@@]2(C1(C)C)[H])C#N)C)CN2C(=O)C1CCC(OC)CC1 HSVCDLWTQGOHLG-PHUNDQRJSA-N 0.000 description 1
- LJCYTZOSRCZIKR-IHNMVGGXSA-N C([C@]1(C2=CC=CC=C2C[C@@]2(C1(C)C)[H])C)CN2C(=O)C1CCC(O)(C(F)(F)F)CC1 Chemical compound C([C@]1(C2=CC=CC=C2C[C@@]2(C1(C)C)[H])C)CN2C(=O)C1CCC(O)(C(F)(F)F)CC1 LJCYTZOSRCZIKR-IHNMVGGXSA-N 0.000 description 1
- LESAIGZOUZXUCP-CKDRMYOASA-N C([C@]1(C2=CC=CC=C2C[C@@]2(C1(C)C)[H])C)CN2C(=O)[C@@H]1CC[C@@H](NC(=O)OC(C)(C)C)C1 Chemical compound C([C@]1(C2=CC=CC=C2C[C@@]2(C1(C)C)[H])C)CN2C(=O)[C@@H]1CC[C@@H](NC(=O)OC(C)(C)C)C1 LESAIGZOUZXUCP-CKDRMYOASA-N 0.000 description 1
- PBTWKVLWUWRYSX-COXJZWCISA-N C([C@]1(C2=CC=CC=C2C[C@@]2(C1(C)C)[H])C)CN2C(=O)[C@H]1CCC[C@@H](CO)C1 Chemical compound C([C@]1(C2=CC=CC=C2C[C@@]2(C1(C)C)[H])C)CN2C(=O)[C@H]1CCC[C@@H](CO)C1 PBTWKVLWUWRYSX-COXJZWCISA-N 0.000 description 1
- 239000004072 C09CA03 - Valsartan Substances 0.000 description 1
- 239000002947 C09CA04 - Irbesartan Substances 0.000 description 1
- 239000002081 C09CA05 - Tasosartan Substances 0.000 description 1
- 239000005537 C09CA07 - Telmisartan Substances 0.000 description 1
- FROKRULIIOJBQH-UHFFFAOYSA-N C12=CC=CC=C2CC2N(C)CCC1(O)C2(C)C Chemical compound C12=CC=CC=C2CC2N(C)CCC1(O)C2(C)C FROKRULIIOJBQH-UHFFFAOYSA-N 0.000 description 1
- AWBZBXWRJDKOJX-IWIQFXGASA-N C1=C2N=CNC2=CC(C(=O)N2CC[C@]3(C4=CC(=CC=C4C[C@@]2([C@H]3C)[H])C(=O)OCC)C)=C1 Chemical compound C1=C2N=CNC2=CC(C(=O)N2CC[C@]3(C4=CC(=CC=C4C[C@@]2([C@H]3C)[H])C(=O)OCC)C)=C1 AWBZBXWRJDKOJX-IWIQFXGASA-N 0.000 description 1
- DOEJOAZSRIFEFK-UHFFFAOYSA-N C1C2(C#N)CCN(C)C1C(=O)C1=CC=C(OC)C=C12 Chemical compound C1C2(C#N)CCN(C)C1C(=O)C1=CC=C(OC)C=C12 DOEJOAZSRIFEFK-UHFFFAOYSA-N 0.000 description 1
- ATQNSZGXSNEKLG-ZBFHGGJFSA-N C1C2=C(C#N)C=CC=C2[C@@]2(C)C(C)(C)[C@@H]1NCC2 Chemical compound C1C2=C(C#N)C=CC=C2[C@@]2(C)C(C)(C)[C@@H]1NCC2 ATQNSZGXSNEKLG-ZBFHGGJFSA-N 0.000 description 1
- TYOHPBZJDCPPJJ-ZBFHGGJFSA-N C1C2=CC(C#N)=CC=C2[C@]2(C)CCN[C@@]1([H])C2(C)C Chemical compound C1C2=CC(C#N)=CC=C2[C@]2(C)CCN[C@@]1([H])C2(C)C TYOHPBZJDCPPJJ-ZBFHGGJFSA-N 0.000 description 1
- CXSVNDHNBLGHFT-WBVHZDCISA-N C1C2=CC(C(C)=O)=CC=C2[C@]2(C)CCN[C@@]1([H])C2(C)C Chemical compound C1C2=CC(C(C)=O)=CC=C2[C@]2(C)CCN[C@@]1([H])C2(C)C CXSVNDHNBLGHFT-WBVHZDCISA-N 0.000 description 1
- ONLIYWIBKWSCOF-SDBXPKJASA-N C1C2=CC(Cl)=C(O)C(Cl)=C2[C@@]2(C)CCN[C@]1([H])C2 Chemical compound C1C2=CC(Cl)=C(O)C(Cl)=C2[C@@]2(C)CCN[C@]1([H])C2 ONLIYWIBKWSCOF-SDBXPKJASA-N 0.000 description 1
- MXPRGYXFQNADQB-UHFFFAOYSA-N C1C2=CC(O)=C(O)C=C2C2(C)C(C)(C)C1NCC2 Chemical compound C1C2=CC(O)=C(O)C=C2C2(C)C(C)(C)C1NCC2 MXPRGYXFQNADQB-UHFFFAOYSA-N 0.000 description 1
- XGTMHMNWQUAXOU-WBVHZDCISA-N C1C2=CC=C(C(C)=O)C=C2[C@]2(C)CCN[C@@]1([H])C2(C)C Chemical compound C1C2=CC=C(C(C)=O)C=C2[C@]2(C)CCN[C@@]1([H])C2(C)C XGTMHMNWQUAXOU-WBVHZDCISA-N 0.000 description 1
- LZKVUUIKJBNQMD-UHFFFAOYSA-N C1C2=CC=C(O)C=C2C2(C(=O)OC)CC1N(C)CC2 Chemical compound C1C2=CC=C(O)C=C2C2(C(=O)OC)CC1N(C)CC2 LZKVUUIKJBNQMD-UHFFFAOYSA-N 0.000 description 1
- YAAOMSJIYNPRSW-WBVHZDCISA-N C1C2=CC=C(S(=O)(=O)N(C)C)C=C2[C@]2(C)CCN[C@@]1([H])C2(C)C Chemical compound C1C2=CC=C(S(=O)(=O)N(C)C)C=C2[C@]2(C)CCN[C@@]1([H])C2(C)C YAAOMSJIYNPRSW-WBVHZDCISA-N 0.000 description 1
- AZADNPHRODWTEJ-ZBFHGGJFSA-N C1C2=CC=C(S(=O)(=O)NC)C=C2[C@]2(C)CCN[C@@]1([H])C2(C)C Chemical compound C1C2=CC=C(S(=O)(=O)NC)C=C2[C@]2(C)CCN[C@@]1([H])C2(C)C AZADNPHRODWTEJ-ZBFHGGJFSA-N 0.000 description 1
- ZNWRPWTXYAUHJW-ZBFHGGJFSA-N C1C2=CC=C(S(C)(=O)=O)C=C2[C@]2(C)CCN[C@@]1([H])C2(C)C Chemical compound C1C2=CC=C(S(C)(=O)=O)C=C2[C@]2(C)CCN[C@@]1([H])C2(C)C ZNWRPWTXYAUHJW-ZBFHGGJFSA-N 0.000 description 1
- VRYRJOJSUWSSFY-HIFRSBDPSA-N C1C2=CC=C(S(N)(=O)=O)C=C2[C@]2(C)CCN[C@@]1([H])C2(C)C Chemical compound C1C2=CC=C(S(N)(=O)=O)C=C2[C@]2(C)CCN[C@@]1([H])C2(C)C VRYRJOJSUWSSFY-HIFRSBDPSA-N 0.000 description 1
- FLMFAVCAJUKCMJ-UHFFFAOYSA-N C1C2C3=CC(OC)=CC=C3C1NC(=O)C2 Chemical compound C1C2C3=CC(OC)=CC=C3C1NC(=O)C2 FLMFAVCAJUKCMJ-UHFFFAOYSA-N 0.000 description 1
- IAWSDVUITZGERM-UHFFFAOYSA-N C1CC(OC)CCC1C(=O)N1C(CC=2C3=CC(O)=CC=2)CC3(C(=O)OC)CC1 Chemical compound C1CC(OC)CCC1C(=O)N1C(CC=2C3=CC(O)=CC=2)CC3(C(=O)OC)CC1 IAWSDVUITZGERM-UHFFFAOYSA-N 0.000 description 1
- WIAMZNAZNYRDMI-UHFFFAOYSA-N C1CC(OC)CCC1C(=O)N1C(CC=2C3=CC=CC=C3NC3=2)CC3CC1 Chemical compound C1CC(OC)CCC1C(=O)N1C(CC=2C3=CC=CC=C3NC3=2)CC3CC1 WIAMZNAZNYRDMI-UHFFFAOYSA-N 0.000 description 1
- FQRKMFOQKZSXPU-WBADCKNFSA-N C1CC(OC)CCC1C(=O)N1[C@H](C2(C)C)CC3=C(S(C)(=O)=O)C=CC=C3[C@@]2(C)CC1 Chemical compound C1CC(OC)CCC1C(=O)N1[C@H](C2(C)C)CC3=C(S(C)(=O)=O)C=CC=C3[C@@]2(C)CC1 FQRKMFOQKZSXPU-WBADCKNFSA-N 0.000 description 1
- MDFBSIGPRMFQBT-UHFFFAOYSA-N CC1(C)C2CC3=C(O)C=CC=C3C1(C)CCN2CC1=CC=CC=C1 Chemical compound CC1(C)C2CC3=C(O)C=CC=C3C1(C)CCN2CC1=CC=CC=C1 MDFBSIGPRMFQBT-UHFFFAOYSA-N 0.000 description 1
- GHHULKUVNUQNMO-DGYXAIABSA-N CCC(=O)N(C)[C@H]1CC[C@H](CC1)C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C Chemical compound CCC(=O)N(C)[C@H]1CC[C@H](CC1)C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C GHHULKUVNUQNMO-DGYXAIABSA-N 0.000 description 1
- FYMPBTZJQBEVCF-PZZZBDDNSA-N CN([C@H]1CC[C@H](CC1)C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C)C(=O)C1=CC=CC=C1 Chemical compound CN([C@H]1CC[C@H](CC1)C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C)C(=O)C1=CC=CC=C1 FYMPBTZJQBEVCF-PZZZBDDNSA-N 0.000 description 1
- YWZPCOCGNXWNPX-UTLGNLBHSA-N CN([C@H]1CC[C@H](CC1)C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C)C(=O)CC1=CC=CC=C1 Chemical compound CN([C@H]1CC[C@H](CC1)C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C)C(=O)CC1=CC=CC=C1 YWZPCOCGNXWNPX-UTLGNLBHSA-N 0.000 description 1
- JYXPQOZUXFHKFL-BMYILPHFSA-N COC(=O)[C@H]1CC[C@@H](CC1)C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C Chemical compound COC(=O)[C@H]1CC[C@@H](CC1)C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C JYXPQOZUXFHKFL-BMYILPHFSA-N 0.000 description 1
- MQTTVQMAXLFPBX-WVVHNUNQSA-N CO[C@@H]1CC[C@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3 Chemical compound CO[C@@H]1CC[C@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3 MQTTVQMAXLFPBX-WVVHNUNQSA-N 0.000 description 1
- MQTTVQMAXLFPBX-COXJZWCISA-N CO[C@H]1CC[C@H](CC1)C(=O)N1CC[C@@]2(C)C3=CC=CC=C3C[C@@H]1C2(C)C Chemical compound CO[C@H]1CC[C@H](CC1)C(=O)N1CC[C@@]2(C)C3=CC=CC=C3C[C@@H]1C2(C)C MQTTVQMAXLFPBX-COXJZWCISA-N 0.000 description 1
- GHOSNRCGJFBJIB-UHFFFAOYSA-N Candesartan cilexetil Chemical compound C=12N(CC=3C=CC(=CC=3)C=3C(=CC=CC=3)C3=NNN=N3)C(OCC)=NC2=CC=CC=1C(=O)OC(C)OC(=O)OC1CCCCC1 GHOSNRCGJFBJIB-UHFFFAOYSA-N 0.000 description 1
- 102100024650 Carbonic anhydrase 3 Human genes 0.000 description 1
- 101710167915 Carbonic anhydrase 3 Proteins 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- 229920001268 Cholestyramine Polymers 0.000 description 1
- FZLWTRLVFXUTLF-UHFFFAOYSA-N ClBr(=O)=O.ClBr(=O)=O.C1=CC=NC=C1 Chemical compound ClBr(=O)=O.ClBr(=O)=O.C1=CC=NC=C1 FZLWTRLVFXUTLF-UHFFFAOYSA-N 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- JVHXJTBJCFBINQ-ADAARDCZSA-N Dapagliflozin Chemical compound C1=CC(OCC)=CC=C1CC1=CC([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=CC=C1Cl JVHXJTBJCFBINQ-ADAARDCZSA-N 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- KKUKTXOBAWVSHC-UHFFFAOYSA-N Dimethylphosphate Chemical compound COP(O)(=O)OC KKUKTXOBAWVSHC-UHFFFAOYSA-N 0.000 description 1
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010011459 Exenatide Proteins 0.000 description 1
- 229910015400 FeC13 Inorganic materials 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 102000027487 Fructose-Bisphosphatase Human genes 0.000 description 1
- 108010017464 Fructose-Bisphosphatase Proteins 0.000 description 1
- 229940098788 GABA receptor antagonist Drugs 0.000 description 1
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 1
- 108091007911 GSKs Proteins 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 229940122904 Glucagon receptor antagonist Drugs 0.000 description 1
- FAEKWTJYAYMJKF-QHCPKHFHSA-N GlucoNorm Chemical compound C1=C(C(O)=O)C(OCC)=CC(CC(=O)N[C@@H](CC(C)C)C=2C(=CC=CC=2)N2CCCCC2)=C1 FAEKWTJYAYMJKF-QHCPKHFHSA-N 0.000 description 1
- 108090000079 Glucocorticoid Receptors Proteins 0.000 description 1
- 102100033417 Glucocorticoid receptor Human genes 0.000 description 1
- 102000030595 Glucokinase Human genes 0.000 description 1
- 108010021582 Glucokinase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003638 Glucose-6-Phosphatase Human genes 0.000 description 1
- 108010086800 Glucose-6-Phosphatase Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000007390 Glycogen Phosphorylase Human genes 0.000 description 1
- 108010046163 Glycogen Phosphorylase Proteins 0.000 description 1
- 102000004103 Glycogen Synthase Kinases Human genes 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 102100030488 HEAT repeat-containing protein 6 Human genes 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 101000990566 Homo sapiens HEAT repeat-containing protein 6 Proteins 0.000 description 1
- 101000801684 Homo sapiens Phospholipid-transporting ATPase ABCA1 Proteins 0.000 description 1
- 101000684208 Homo sapiens Prolyl endopeptidase FAP Proteins 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- QZRGKCOWNLSUDK-UHFFFAOYSA-N Iodochlorine Chemical compound ICl QZRGKCOWNLSUDK-UHFFFAOYSA-N 0.000 description 1
- 102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 1
- 108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- LTXREWYXXSTFRX-QGZVFWFLSA-N Linagliptin Chemical compound N=1C=2N(C)C(=O)N(CC=3N=C4C=CC=CC4=C(C)N=3)C(=O)C=2N(CC#CC)C=1N1CCC[C@@H](N)C1 LTXREWYXXSTFRX-QGZVFWFLSA-N 0.000 description 1
- 206010054805 Macroangiopathy Diseases 0.000 description 1
- 206010027417 Metabolic acidosis Diseases 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- SCXFFGSMQHWMEQ-TXFRFBGQSA-N N([C@@H]1CC[C@H](C1)C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C)C(=O)NC1=CC=CC=C1 Chemical compound N([C@@H]1CC[C@H](C1)C(=O)N1CC[C@@]2(C)C3=CC=CC(O)=C3C[C@@H]1C2(C)C)C(=O)NC1=CC=CC=C1 SCXFFGSMQHWMEQ-TXFRFBGQSA-N 0.000 description 1
- MGJKQDOBUOMPEZ-UHFFFAOYSA-N N,N'-dimethylurea Chemical compound CNC(=O)NC MGJKQDOBUOMPEZ-UHFFFAOYSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- 238000007126 N-alkylation reaction Methods 0.000 description 1
- QARQATWGBYRNRZ-PNYWAOBFSA-N N-ethyl-2-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]pyrrolidine-1-carboxamide Chemical compound CCNC(=O)N1CCCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 QARQATWGBYRNRZ-PNYWAOBFSA-N 0.000 description 1
- SZDCVTCHDYNJRA-DZHRLERZSA-N N-ethyl-3-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]piperidine-1-carboxamide Chemical compound C1N(C(=O)NCC)CCCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 SZDCVTCHDYNJRA-DZHRLERZSA-N 0.000 description 1
- ABHOHBUEUBKBOY-WQMGONBFSA-N N-ethyl-3-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]pyrrolidine-1-carboxamide Chemical compound C1N(C(=O)NCC)CCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 ABHOHBUEUBKBOY-WQMGONBFSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- AKTQSHIRSZYKJS-UHFFFAOYSA-N N-methylmethanamine Chemical compound CNC.CNC AKTQSHIRSZYKJS-UHFFFAOYSA-N 0.000 description 1
- MXOBEVQNXADHPV-AGIAAFPJSA-N N1([C@@H]2CC3=C([C@@](CC1)(C)C2(C)C)C=CC=C3C(=O)OCC)C(=O)C1CCC(OC)CC1 Chemical compound N1([C@@H]2CC3=C([C@@](CC1)(C)C2(C)C)C=CC=C3C(=O)OCC)C(=O)C1CCC(OC)CC1 MXOBEVQNXADHPV-AGIAAFPJSA-N 0.000 description 1
- JRBJHUIPYFKRQH-UHFFFAOYSA-N N1C2=CC=CC=C2C(C2)=C1C1CCNC2C1 Chemical compound N1C2=CC=CC=C2C(C2)=C1C1CCNC2C1 JRBJHUIPYFKRQH-UHFFFAOYSA-N 0.000 description 1
- YBUQBJAALKBPDP-AEFFLSMTSA-N N1CC[C@@]2(C)C(C=C3N=C(N(C3=C3)C)C)=C3C[C@@H]1C2(C)C Chemical compound N1CC[C@@]2(C)C(C=C3N=C(N(C3=C3)C)C)=C3C[C@@H]1C2(C)C YBUQBJAALKBPDP-AEFFLSMTSA-N 0.000 description 1
- QDXIAPPZXGGVGN-WBVHZDCISA-N N1CC[C@@]2(C)C(C=C3N=CN(C3=C3)C)=C3C[C@@H]1C2(C)C Chemical compound N1CC[C@@]2(C)C(C=C3N=CN(C3=C3)C)=C3C[C@@H]1C2(C)C QDXIAPPZXGGVGN-WBVHZDCISA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 101150111774 NPY5R gene Proteins 0.000 description 1
- ZGZNUOLTELNHJS-FKEBMKQQSA-N N[C@H]1CC[C@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3O Chemical compound N[C@H]1CC[C@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3O ZGZNUOLTELNHJS-FKEBMKQQSA-N 0.000 description 1
- 102000003729 Neprilysin Human genes 0.000 description 1
- 108090000028 Neprilysin Proteins 0.000 description 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
- KEJOCWOXCDWNID-UHFFFAOYSA-N Nitrilooxonium Chemical compound [O+]#N KEJOCWOXCDWNID-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- LFPGIWGIXKZJHT-IKLMUHQQSA-N OC1=CC=CC2=C1C[C@H]1N(CC[C@@]2(C1(C)C)C)C(=O)[C@H]1CC[C@H](CC1)C(C(=O)N)(C)C Chemical compound OC1=CC=CC2=C1C[C@H]1N(CC[C@@]2(C1(C)C)C)C(=O)[C@H]1CC[C@H](CC1)C(C(=O)N)(C)C LFPGIWGIXKZJHT-IKLMUHQQSA-N 0.000 description 1
- CEFAAUYRMQVAAQ-SDEMEJOHSA-N OC1=CC=CC2=C1C[C@H]1N(CC[C@@]2(C1(C)C)C)C(=O)[C@H]1CC[C@H](CC1)C(C(=O)N)C Chemical compound OC1=CC=CC2=C1C[C@H]1N(CC[C@@]2(C1(C)C)C)C(=O)[C@H]1CC[C@H](CC1)C(C(=O)N)C CEFAAUYRMQVAAQ-SDEMEJOHSA-N 0.000 description 1
- HQAMKLQUESOKKZ-GSGUIUBRSA-N OC1=CC=CC2=C1C[C@H]1N(CC[C@@]2(C1(C)C)C)C(=O)[C@H]1CC[C@H](CC1)C(C(=O)N)C1=CC=CC=C1 Chemical compound OC1=CC=CC2=C1C[C@H]1N(CC[C@@]2(C1(C)C)C)C(=O)[C@H]1CC[C@H](CC1)C(C(=O)N)C1=CC=CC=C1 HQAMKLQUESOKKZ-GSGUIUBRSA-N 0.000 description 1
- KXPYOUVPXXMOLS-RMVNPTQUSA-N OC1=CC=CC2=C1C[C@H]1N(CC[C@@]2(C1(C)C)C)C(=O)[C@H]1CC[C@H](CC1)C(C(=O)N)CC Chemical compound OC1=CC=CC2=C1C[C@H]1N(CC[C@@]2(C1(C)C)C)C(=O)[C@H]1CC[C@H](CC1)C(C(=O)N)CC KXPYOUVPXXMOLS-RMVNPTQUSA-N 0.000 description 1
- IELYAKMNJRKUTN-NFFAJSBLSA-N OC1=CC=CC2=C1C[C@H]1N(CC[C@@]2(C1(C)C)C)C(=O)[C@H]1CC[C@H](CC1)C1=C(C(=O)N)C=CC=C1 Chemical compound OC1=CC=CC2=C1C[C@H]1N(CC[C@@]2(C1(C)C)C)C(=O)[C@H]1CC[C@H](CC1)C1=C(C(=O)N)C=CC=C1 IELYAKMNJRKUTN-NFFAJSBLSA-N 0.000 description 1
- XYEREIMNNQGVQK-ZTBQPFKDSA-N OC1=CC=CC2=C1C[C@H]1N(CC[C@@]2(C1(C)C)C)C(=O)[C@H]1CC[C@H](CC1)CC(=O)N Chemical compound OC1=CC=CC2=C1C[C@H]1N(CC[C@@]2(C1(C)C)C)C(=O)[C@H]1CC[C@H](CC1)CC(=O)N XYEREIMNNQGVQK-ZTBQPFKDSA-N 0.000 description 1
- VTKJPJMEJJQIAM-UYWGQIMJSA-N OC[C@@H]1CC[C@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3 Chemical compound OC[C@@H]1CC[C@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3 VTKJPJMEJJQIAM-UYWGQIMJSA-N 0.000 description 1
- VTKJPJMEJJQIAM-UGBDLMATSA-N OC[C@H]1CC[C@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3 Chemical compound OC[C@H]1CC[C@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3 VTKJPJMEJJQIAM-UGBDLMATSA-N 0.000 description 1
- ZMTJRVAMGLVTBB-AWGCWCAXSA-N O[C@@H]1CC[C@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3 Chemical compound O[C@@H]1CC[C@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3 ZMTJRVAMGLVTBB-AWGCWCAXSA-N 0.000 description 1
- ZNOWDBTVMJEFSD-CQIVLNHVSA-N O[C@@H]1CC[C@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3O Chemical compound O[C@@H]1CC[C@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3O ZNOWDBTVMJEFSD-CQIVLNHVSA-N 0.000 description 1
- ZNOWDBTVMJEFSD-FKEBMKQQSA-N O[C@H]1CC[C@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3O Chemical compound O[C@H]1CC[C@H](CC1)C(=O)N1[C@@H]2CC3=C([C@](CC1)(C2(C)C)C)C=CC=C3O ZNOWDBTVMJEFSD-FKEBMKQQSA-N 0.000 description 1
- 206010030043 Ocular hypertension Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005480 Olmesartan Substances 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 108010016731 PPAR gamma Proteins 0.000 description 1
- 102100038824 Peroxisome proliferator-activated receptor delta Human genes 0.000 description 1
- 102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102100040918 Pro-glucagon Human genes 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229940123924 Protein kinase C inhibitor Drugs 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
- 238000000297 Sandmeyer reaction Methods 0.000 description 1
- 238000006350 Schiemann fluorination reaction Methods 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229940123518 Sodium/glucose cotransporter 2 inhibitor Drugs 0.000 description 1
- 238000003477 Sonogashira cross-coupling reaction Methods 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000006619 Stille reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229940123464 Thiazolidinedione Drugs 0.000 description 1
- 229910010066 TiC14 Inorganic materials 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 102000008316 Type 4 Melanocortin Receptor Human genes 0.000 description 1
- 108010021436 Type 4 Melanocortin Receptor Proteins 0.000 description 1
- 101710204865 Tyrosine-protein phosphatase 1 Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229940116731 Uricosuric agent Drugs 0.000 description 1
- 238000005874 Vilsmeier-Haack formylation reaction Methods 0.000 description 1
- FZNCGRZWXLXZSZ-CIQUZCHMSA-N Voglibose Chemical compound OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O FZNCGRZWXLXZSZ-CIQUZCHMSA-N 0.000 description 1
- BLVZSMPXCIXJFM-LQBHMHGISA-N [(1R,9R,13R)-5-cyano-1,13-dimethyl-10-(2,2,2-trifluoroacetyl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-yl] trifluoromethanesulfonate Chemical compound C1C2=CC(C#N)=C(OS(=O)(=O)C(F)(F)F)C=C2[C@@]2(C)[C@@H](C)[C@@H]1N(C(=O)C(F)(F)F)CC2 BLVZSMPXCIXJFM-LQBHMHGISA-N 0.000 description 1
- WMCLAHJLCTWGGR-TVAWFJOGSA-N [(1S,2S,4R)-2-bicyclo[2.2.1]hept-5-enyl]-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound [C@@H]12[C@H](C[C@H](C=C1)C2)C(=O)N2[C@@H]1CC3=C([C@](CC2)(C1(C)C)C)C=CC=C3O WMCLAHJLCTWGGR-TVAWFJOGSA-N 0.000 description 1
- ZCQAEUKXOLANKS-QFHNSRLUSA-N [(1S,9R)-6-fluoro-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(4-methoxycyclohexyl)methanone Chemical compound C1CC(OC)CCC1C(=O)N1[C@@H](C2(C)C)CC3=C(F)C=CC=C3[C@]2(C)CC1 ZCQAEUKXOLANKS-QFHNSRLUSA-N 0.000 description 1
- MYOIOKNZUWUVBP-BIVZGKPNSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(1-methylpiperidin-2-yl)methanone Chemical compound CN1CCCCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 MYOIOKNZUWUVBP-BIVZGKPNSA-N 0.000 description 1
- HTYLCUNJUZHXEC-IBWUSFKPSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(1-methylpiperidin-3-yl)methanone Chemical compound C1N(C)CCCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 HTYLCUNJUZHXEC-IBWUSFKPSA-N 0.000 description 1
- DRTYSNLMZHQFMN-BIVZGKPNSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(1-methylsulfonylpiperidin-2-yl)methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCCCN1S(C)(=O)=O DRTYSNLMZHQFMN-BIVZGKPNSA-N 0.000 description 1
- KLSNYAQBHQRFLB-IBWUSFKPSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(1-methylsulfonylpiperidin-3-yl)methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCCN(S(C)(=O)=O)C1 KLSNYAQBHQRFLB-IBWUSFKPSA-N 0.000 description 1
- NGBMMPCXVBDZGU-OHIWNTBFSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(1-methylsulfonylpyrrolidin-2-yl)methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCCN1S(C)(=O)=O NGBMMPCXVBDZGU-OHIWNTBFSA-N 0.000 description 1
- UAYSJUSJOCUTPF-VXOHXDMYSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(1-methylsulfonylpyrrolidin-3-yl)methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCN(S(C)(=O)=O)C1 UAYSJUSJOCUTPF-VXOHXDMYSA-N 0.000 description 1
- ODHNZSZBDKFYCO-BVAGGSTKSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(1-phenylcyclopentyl)methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1(C=2C=CC=CC=2)CCCC1 ODHNZSZBDKFYCO-BVAGGSTKSA-N 0.000 description 1
- WBWWMRBLENUFLB-VCJXRDTASA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(1-propylpiperidin-2-yl)methanone Chemical compound CCCN1CCCCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 WBWWMRBLENUFLB-VCJXRDTASA-N 0.000 description 1
- LQIBQKJUPJGWMQ-QFHNSRLUSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(3-methoxycyclohexyl)methanone Chemical compound C1C(OC)CCCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 LQIBQKJUPJGWMQ-QFHNSRLUSA-N 0.000 description 1
- FPSDTUMOZJNGET-QFHNSRLUSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(3-methylcyclohexyl)methanone Chemical compound C1C(C)CCCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 FPSDTUMOZJNGET-QFHNSRLUSA-N 0.000 description 1
- BMKCMPYMLCCZIQ-QFHNSRLUSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(4-methoxycyclohexyl)methanone Chemical compound C1CC(OC)CCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 BMKCMPYMLCCZIQ-QFHNSRLUSA-N 0.000 description 1
- SOBPRKYWNXHBRR-QFHNSRLUSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(4-methylcyclohexyl)methanone Chemical compound C1CC(C)CCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 SOBPRKYWNXHBRR-QFHNSRLUSA-N 0.000 description 1
- HSSYRASWHQMLNW-PSPLIBJGSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(4-propan-2-ylcyclohexyl)methanone Chemical compound C1CC(C(C)C)CCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 HSSYRASWHQMLNW-PSPLIBJGSA-N 0.000 description 1
- REPZAZSNNREKDU-PSPLIBJGSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-(4-propylcyclohexyl)methanone Chemical compound C1CC(CCC)CCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 REPZAZSNNREKDU-PSPLIBJGSA-N 0.000 description 1
- XVVLUMSQAZOVPZ-CDXJDZJCSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-[(2S)-1-methylpyrrolidin-2-yl]methanone Chemical compound CN1CCC[C@H]1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 XVVLUMSQAZOVPZ-CDXJDZJCSA-N 0.000 description 1
- RPANTDYJIRKGBE-QFHNSRLUSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-[4-(methylamino)cyclohexyl]methanone Chemical compound C1CC(NC)CCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 RPANTDYJIRKGBE-QFHNSRLUSA-N 0.000 description 1
- VQCXOHMJHSUDDB-DFWLKAPTSA-N [(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-pyrrolidin-2-ylmethanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCCN1 VQCXOHMJHSUDDB-DFWLKAPTSA-N 0.000 description 1
- WMCLAHJLCTWGGR-CEHTULJQSA-N [(2S)-2-bicyclo[2.2.1]hept-5-enyl]-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C1C2=C(O)C=CC=C2[C@@]2(C)C(C)(C)[C@@H]1N(C(=O)[C@@H]1C3CC(C=C3)C1)CC2 WMCLAHJLCTWGGR-CEHTULJQSA-N 0.000 description 1
- KPSWJGSEHDRZKW-JMYJPSAUSA-N [1-(benzenesulfonyl)piperidin-2-yl]-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCCCN1S(=O)(=O)C1=CC=CC=C1 KPSWJGSEHDRZKW-JMYJPSAUSA-N 0.000 description 1
- BRPZCJGSKSDYMD-NKGOGPNWSA-N [1-(benzenesulfonyl)piperidin-3-yl]-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C(C1)CCCN1S(=O)(=O)C1=CC=CC=C1 BRPZCJGSKSDYMD-NKGOGPNWSA-N 0.000 description 1
- STXNIVRJXOINBN-AGRRDESQSA-N [1-(benzenesulfonyl)pyrrolidin-2-yl]-[(1S,9R)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCCN1S(=O)(=O)C1=CC=CC=C1 STXNIVRJXOINBN-AGRRDESQSA-N 0.000 description 1
- KVSOQQQUFXGJCV-ZIHXJKBXSA-N [1-(benzenesulfonyl)pyrrolidin-2-yl]-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCCN1S(=O)(=O)C1=CC=CC=C1 KVSOQQQUFXGJCV-ZIHXJKBXSA-N 0.000 description 1
- DKJZPSUYUZSDQC-NAMYIYEPSA-N [1-(benzenesulfonyl)pyrrolidin-3-yl]-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C(C1)CCN1S(=O)(=O)C1=CC=CC=C1 DKJZPSUYUZSDQC-NAMYIYEPSA-N 0.000 description 1
- FDKIDFYIEWFERB-UHFFFAOYSA-N [2-butyl-5-chloro-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol;potassium Chemical compound [K].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C=2NN=NN=2)C=C1 FDKIDFYIEWFERB-UHFFFAOYSA-N 0.000 description 1
- LEKNEZOKYBDTBI-QFHNSRLUSA-N [4-(hydroxymethyl)cyclohexyl]-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCC(CO)CC1 LEKNEZOKYBDTBI-QFHNSRLUSA-N 0.000 description 1
- JFBZPFYRPYOZCQ-UHFFFAOYSA-N [Li].[Al] Chemical compound [Li].[Al] JFBZPFYRPYOZCQ-UHFFFAOYSA-N 0.000 description 1
- DXCUXDJEJYOGRW-UHFFFAOYSA-N [Na].CC(CC1=CC=CC=C1)N1CCC(=CC1)C Chemical compound [Na].CC(CC1=CC=CC=C1)N1CCC(=CC1)C DXCUXDJEJYOGRW-UHFFFAOYSA-N 0.000 description 1
- NNTGAOLTGGLLPE-UHFFFAOYSA-N [Zn+2].[C-]#[C-] Chemical class [Zn+2].[C-]#[C-] NNTGAOLTGGLLPE-UHFFFAOYSA-N 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 150000001264 acyl cyanides Chemical class 0.000 description 1
- 150000001265 acyl fluorides Chemical class 0.000 description 1
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 1
- 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 description 1
- 229940127252 advanced glycation end product inhibitor Drugs 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003288 aldose reductase inhibitor Substances 0.000 description 1
- 229940090865 aldose reductase inhibitors used in diabetes Drugs 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000002355 alkine group Chemical group 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- ZSBOMTDTBDDKMP-OAHLLOKOSA-N alogliptin Chemical compound C=1C=CC=C(C#N)C=1CN1C(=O)N(C)C(=O)C=C1N1CCC[C@@H](N)C1 ZSBOMTDTBDDKMP-OAHLLOKOSA-N 0.000 description 1
- 229960001667 alogliptin Drugs 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- 102000030484 alpha-2 Adrenergic Receptor Human genes 0.000 description 1
- 108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229940126317 angiotensin II receptor antagonist Drugs 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000001837 anti-cortisol effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229940125708 antidiabetic agent Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 239000003705 antithrombocytic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000005163 aryl sulfanyl group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960005370 atorvastatin Drugs 0.000 description 1
- 229950010046 avasimibe Drugs 0.000 description 1
- 108010014210 axokine Proteins 0.000 description 1
- XTKDAFGWCDAMPY-UHFFFAOYSA-N azaperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCN(C=2N=CC=CC=2)CC1 XTKDAFGWCDAMPY-UHFFFAOYSA-N 0.000 description 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- XXRGLCKZBCIEKO-DLMDZQPMSA-N azocine Chemical compound C/1=C/C=C\N=C/C=C\1 XXRGLCKZBCIEKO-DLMDZQPMSA-N 0.000 description 1
- 125000005603 azodicarboxylic group Chemical group 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- JPYQFYIEOUVJDU-UHFFFAOYSA-N beclamide Chemical compound ClCCC(=O)NCC1=CC=CC=C1 JPYQFYIEOUVJDU-UHFFFAOYSA-N 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- JQAZZGUHCPFVPG-RMPZQUOJSA-N benzyl 3-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]piperidine-1-carboxylate Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C(C1)CCCN1C(=O)OCC1=CC=CC=C1 JQAZZGUHCPFVPG-RMPZQUOJSA-N 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000638 benzylaminocarbonyl group Chemical group C(C1=CC=CC=C1)NC(=O)* 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- IIBYAHWJQTYFKB-UHFFFAOYSA-N bezafibrate Chemical compound C1=CC(OC(C)(C)C(O)=O)=CC=C1CCNC(=O)C1=CC=C(Cl)C=C1 IIBYAHWJQTYFKB-UHFFFAOYSA-N 0.000 description 1
- 229960000516 bezafibrate Drugs 0.000 description 1
- 150000005350 bicyclononyls Chemical group 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- UCYRAEIHXSVXPV-UHFFFAOYSA-K bis(trifluoromethylsulfonyloxy)indiganyl trifluoromethanesulfonate Chemical compound [In+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F UCYRAEIHXSVXPV-UHFFFAOYSA-K 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 125000005620 boronic acid group Chemical class 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- MMLSWLZTJDJYJH-UHFFFAOYSA-N calcium;propan-2-olate Chemical compound [Ca+2].CC(C)[O-].CC(C)[O-] MMLSWLZTJDJYJH-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229960004349 candesartan cilexetil Drugs 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000003874 central nervous system depressant Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- JUFFVKRROAPVBI-PVOYSMBESA-N chembl1210015 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@H]1[C@@H]([C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@]3(O[C@@H](C[C@H](O)[C@H](O)CO)[C@H](NC(C)=O)[C@@H](O)C3)C(O)=O)O2)O)[C@@H](CO)O1)NC(C)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 JUFFVKRROAPVBI-PVOYSMBESA-N 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- QOPVNWQGBQYBBP-UHFFFAOYSA-N chloroethyl chloroformate Chemical compound CC(Cl)OC(Cl)=O QOPVNWQGBQYBBP-UHFFFAOYSA-N 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- 239000003354 cholesterol ester transfer protein inhibitor Substances 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000002967 competitive immunoassay Methods 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- FDIRIOAEXPIEBL-UHFFFAOYSA-L copper;thiophene-2-carboxylate Chemical compound [Cu+2].[O-]C(=O)C1=CC=CS1.[O-]C(=O)C1=CC=CS1 FDIRIOAEXPIEBL-UHFFFAOYSA-L 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 229940112669 cuprous oxide Drugs 0.000 description 1
- KRFJLUBVMFXRPN-UHFFFAOYSA-N cuprous oxide Chemical compound [O-2].[Cu+].[Cu+] KRFJLUBVMFXRPN-UHFFFAOYSA-N 0.000 description 1
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- BWZXRLYBWSFWCX-OFNKIYASSA-N cycloheptyl-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCCCCC1 BWZXRLYBWSFWCX-OFNKIYASSA-N 0.000 description 1
- ARUKYTASOALXFG-UHFFFAOYSA-N cycloheptylcycloheptane Chemical group C1CCCCCC1C1CCCCCC1 ARUKYTASOALXFG-UHFFFAOYSA-N 0.000 description 1
- 150000001934 cyclohexanes Chemical class 0.000 description 1
- ZHGASCUQXLPSDT-UHFFFAOYSA-N cyclohexanesulfonic acid Chemical compound OS(=O)(=O)C1CCCCC1 ZHGASCUQXLPSDT-UHFFFAOYSA-N 0.000 description 1
- WVIIMZNLDWSIRH-UHFFFAOYSA-N cyclohexylcyclohexane Chemical group C1CCCCC1C1CCCCC1 WVIIMZNLDWSIRH-UHFFFAOYSA-N 0.000 description 1
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- NLUNLVTVUDIHFE-UHFFFAOYSA-N cyclooctylcyclooctane Chemical group C1CCCCCCC1C1CCCCCCC1 NLUNLVTVUDIHFE-UHFFFAOYSA-N 0.000 description 1
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 1
- WEPUZBYKXNKSDH-UHFFFAOYSA-N cyclopentanecarbonyl chloride Chemical compound ClC(=O)C1CCCC1 WEPUZBYKXNKSDH-UHFFFAOYSA-N 0.000 description 1
- LQXNITMKUOQOJB-QURLWZIUSA-N cyclopentyl-[(1R,9R,13R)-4-methoxy-1,13-dimethyl-3,5-dinitro-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]methanone Chemical compound C([C@]1(C2=C(C(OC)=C(C=C2C[C@@]2([C@@H]1C)[H])[N+]([O-])=O)[N+]([O-])=O)C)CN2C(=O)C1CCCC1 LQXNITMKUOQOJB-QURLWZIUSA-N 0.000 description 1
- KSNIZNDDSPXXGX-NQIIRXRSSA-N cyclopentyl-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methanone Chemical compound C([C@@]1(C)C2=CC=CC(O)=C2C[C@@H]2C1(C)C)CN2C(=O)C1CCCC1 KSNIZNDDSPXXGX-NQIIRXRSSA-N 0.000 description 1
- YTGJDPFEXTXYGB-HNAYVOBHSA-N cyclopentyl-[(2r,6r)-8-hydroxy-6-methyl-1,2,5,6-tetrahydro-4h-2,6-methano-benzo[d]azocin-3-yl]-methanone Chemical compound C([C@]1(C2=CC(O)=CC=C2C[C@]2(C1)[H])C)CN2C(=O)C1CCCC1 YTGJDPFEXTXYGB-HNAYVOBHSA-N 0.000 description 1
- PFBDZGFGVJPEIC-OXJNMPFZSA-N cyclopentyl-[(2r,6r)-8-methoxy-6-methyl-1,2,5,6-tetrahydro-4h-2,6-methano-benzo[d]azocin-3-yl]-methanone Chemical compound C([C@]1(C2=CC(OC)=CC=C2C[C@]2(C1)[H])C)CN2C(=O)C1CCCC1 PFBDZGFGVJPEIC-OXJNMPFZSA-N 0.000 description 1
- DLTBAYKGXREKMW-UHFFFAOYSA-N cyclopropanesulfonic acid Chemical compound OS(=O)(=O)C1CC1 DLTBAYKGXREKMW-UHFFFAOYSA-N 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 229960003834 dapagliflozin Drugs 0.000 description 1
- 238000006264 debenzylation reaction Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000002074 deregulated effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- PBGGNZZGJIKBMJ-UHFFFAOYSA-N di(propan-2-yl)azanide Chemical compound CC(C)[N-]C(C)C PBGGNZZGJIKBMJ-UHFFFAOYSA-N 0.000 description 1
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical class C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
- RJGHQTVXGKYATR-UHFFFAOYSA-L dibutyl(dichloro)stannane Chemical compound CCCC[Sn](Cl)(Cl)CCCC RJGHQTVXGKYATR-UHFFFAOYSA-L 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- 125000006263 dimethyl aminosulfonyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- DWLVWMUCHSLGSU-UHFFFAOYSA-N dimethylcarbamic acid Chemical compound CN(C)C(O)=O DWLVWMUCHSLGSU-UHFFFAOYSA-N 0.000 description 1
- ZWWCURLKEXEFQT-UHFFFAOYSA-N dinitrogen pentoxide Inorganic materials [O-][N+](=O)O[N+]([O-])=O ZWWCURLKEXEFQT-UHFFFAOYSA-N 0.000 description 1
- SXZIXHOMFPUIRK-UHFFFAOYSA-N diphenylmethanimine Chemical compound C=1C=CC=CC=1C(=N)C1=CC=CC=C1 SXZIXHOMFPUIRK-UHFFFAOYSA-N 0.000 description 1
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008846 dynamic interplay Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000007345 electrophilic aromatic substitution reaction Methods 0.000 description 1
- 238000007350 electrophilic reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960000573 eprosartan mesylate Drugs 0.000 description 1
- DJSLTDBPKHORNY-XMMWENQYSA-N eprosartan methanesulfonate Chemical compound CS(O)(=O)=O.C=1C=C(C(O)=O)C=CC=1CN1C(CCCC)=NC=C1\C=C(C(O)=O)/CC1=CC=CS1 DJSLTDBPKHORNY-XMMWENQYSA-N 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- DBFZVMSTQYLDDA-UHFFFAOYSA-N ethyl 1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-5-carboxylate Chemical compound N1CCC2(C)C3=CC=C(C(=O)OCC)C=C3CC1C2(C)C DBFZVMSTQYLDDA-UHFFFAOYSA-N 0.000 description 1
- PEWSKOOIVLOUNW-UHFFFAOYSA-N ethyl 10-(4-methoxycyclohexanecarbonyl)-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-5-carboxylate Chemical compound C=1C(C(=O)OCC)=CC=C(C(CC2)(C)C3(C)C)C=1CC3N2C(=O)C1CCC(OC)CC1 PEWSKOOIVLOUNW-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- 125000006260 ethylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- GWQVMPWSEVRGPY-UHFFFAOYSA-N europium cryptate Chemical compound [Eu+3].N=1C2=CC=CC=1CN(CC=1N=C(C=CC=1)C=1N=C(C3)C=CC=1)CC(N=1)=CC(C(=O)NCCN)=CC=1C(N=1)=CC(C(=O)NCCN)=CC=1CN3CC1=CC=CC2=N1 GWQVMPWSEVRGPY-UHFFFAOYSA-N 0.000 description 1
- 229960001519 exenatide Drugs 0.000 description 1
- OLNTVTPDXPETLC-XPWALMASSA-N ezetimibe Chemical compound N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 description 1
- 229960000815 ezetimibe Drugs 0.000 description 1
- ZZCHHVUQYRMYLW-HKBQPEDESA-N farglitazar Chemical compound N([C@@H](CC1=CC=C(C=C1)OCCC=1N=C(OC=1C)C=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1C(=O)C1=CC=CC=C1 ZZCHHVUQYRMYLW-HKBQPEDESA-N 0.000 description 1
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 1
- 229960002297 fenofibrate Drugs 0.000 description 1
- 229940125753 fibrate Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- OKSYMZKKVJYKKJ-UHFFFAOYSA-N furan-2-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=CO1 OKSYMZKKVJYKKJ-UHFFFAOYSA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229960004580 glibenclamide Drugs 0.000 description 1
- WIGIZIANZCJQQY-RUCARUNLSA-N glimepiride Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C=C1 WIGIZIANZCJQQY-RUCARUNLSA-N 0.000 description 1
- 229960004346 glimepiride Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 230000009229 glucose formation Effects 0.000 description 1
- 208000018914 glucose metabolism disease Diseases 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 229940116364 hard fat Drugs 0.000 description 1
- 150000002390 heteroarenes Chemical class 0.000 description 1
- 125000005553 heteroaryloxy group Chemical group 0.000 description 1
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical class C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 1
- 229960000443 hydrochloric acid Drugs 0.000 description 1
- 229960002003 hydrochlorothiazide Drugs 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 230000035879 hyperinsulinaemia Effects 0.000 description 1
- CUILPNURFADTPE-UHFFFAOYSA-N hypobromous acid Chemical compound BrO CUILPNURFADTPE-UHFFFAOYSA-N 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 239000002608 ionic liquid Substances 0.000 description 1
- YCPOHTHPUREGFM-UHFFFAOYSA-N irbesartan Chemical compound O=C1N(CC=2C=CC(=CC=2)C=2C(=CC=CC=2)C=2[N]N=NN=2)C(CCCC)=NC21CCCC2 YCPOHTHPUREGFM-UHFFFAOYSA-N 0.000 description 1
- 229960002198 irbesartan Drugs 0.000 description 1
- PVFSDGKDKFSOTB-UHFFFAOYSA-K iron(3+);triacetate Chemical compound [Fe+3].CC([O-])=O.CC([O-])=O.CC([O-])=O PVFSDGKDKFSOTB-UHFFFAOYSA-K 0.000 description 1
- 125000006328 iso-butylcarbonyl group Chemical group [H]C([H])([H])C([H])(C(*)=O)C([H])([H])[H] 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 230000004140 ketosis Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 150000003951 lactams Chemical group 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229960004873 levomenthol Drugs 0.000 description 1
- 229960002397 linagliptin Drugs 0.000 description 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical class [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- ZEUXAIYYDDCIRX-UHFFFAOYSA-N losartan carboxylic acid Chemical compound CCCCC1=NC(Cl)=C(C(O)=O)N1CC1=CC=C(C=2C(=CC=CC=2)C2=NNN=N2)C=C1 ZEUXAIYYDDCIRX-UHFFFAOYSA-N 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- BMFJHWYMPFMIOD-ZTBQPFKDSA-N methyl (1S,3R)-3-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]cyclohexane-1-carboxylate Chemical compound C1[C@@H](C(=O)OC)CCC[C@H]1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 BMFJHWYMPFMIOD-ZTBQPFKDSA-N 0.000 description 1
- BFPSZKAAMVVPPF-UHFFFAOYSA-N methyl 2-(3-hydroxyimino-6-methoxy-1,2-dihydroinden-1-yl)acetate Chemical compound C1=C(OC)C=C2C(CC(=O)OC)CC(=NO)C2=C1 BFPSZKAAMVVPPF-UHFFFAOYSA-N 0.000 description 1
- HZJMFIUHINHXSY-UHFFFAOYSA-N methyl 2-(3-hydroxyimino-6-methoxy-1,2-dihydroinden-1-yl)acetate methyl 2-(6-methoxy-3-oxo-1,2-dihydroinden-1-yl)acetate Chemical compound COC(CC1CC(C2=CC=C(C=C12)OC)=O)=O.COC(CC1CC(C2=CC=C(C=C12)OC)=NO)=O HZJMFIUHINHXSY-UHFFFAOYSA-N 0.000 description 1
- XXYJMAJGBMPORY-UHFFFAOYSA-N methyl 2-(6-methoxy-3-oxo-1,2-dihydroinden-1-yl)acetate Chemical compound C1=C(OC)C=C2C(CC(=O)OC)CC(=O)C2=C1 XXYJMAJGBMPORY-UHFFFAOYSA-N 0.000 description 1
- BMFJHWYMPFMIOD-KFDQFKALSA-N methyl 3-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]cyclohexane-1-carboxylate Chemical compound C1C(C(=O)OC)CCCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 BMFJHWYMPFMIOD-KFDQFKALSA-N 0.000 description 1
- DGRFOYHUPAOKRP-UHFFFAOYSA-N methyl 4-hydroxy-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-1-carboxylate Chemical compound C1C2=CC=C(O)C=C2C2(C(=O)OC)CC1NCC2 DGRFOYHUPAOKRP-UHFFFAOYSA-N 0.000 description 1
- BOFUTCAJFRTEPT-UHFFFAOYSA-N methyl 4-methoxy-10-methyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-1-carboxylate Chemical compound C1C2=CC=C(OC)C=C2C2(C(=O)OC)CC1N(C)CC2 BOFUTCAJFRTEPT-UHFFFAOYSA-N 0.000 description 1
- YAGKNMSACMMBTL-UHFFFAOYSA-N methyl 8-hydroxy-4-methoxy-10-methyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-1-carboxylate Chemical compound OC1C2=CC=C(OC)C=C2C2(C(=O)OC)CC1N(C)CC2 YAGKNMSACMMBTL-UHFFFAOYSA-N 0.000 description 1
- 125000006261 methyl amino sulfonyl group Chemical group [H]N(C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 150000005217 methyl ethers Chemical class 0.000 description 1
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- HQXKKQDTQDYERH-UHFFFAOYSA-N n'-cyclohexyl-n-(2-morpholin-4-ylethyl)methanediimine;methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1.C1CCCCC1N=C=NCCN1CCOCC1 HQXKKQDTQDYERH-UHFFFAOYSA-N 0.000 description 1
- GDHVAFNGEXASMP-UHFFFAOYSA-N n-[2-[6-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]quinolin-2-yl]phenyl]-1,1,1-trifluoromethanesulfonamide Chemical compound CCC1=NC2=C(C)C=C(C)N=C2N1CC(C=C1C=C2)=CC=C1N=C2C1=CC=CC=C1NS(=O)(=O)C(F)(F)F GDHVAFNGEXASMP-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006252 n-propylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 239000003887 narcotic antagonist Substances 0.000 description 1
- OELFLUMRDSZNSF-BRWVUGGUSA-N nateglinide Chemical compound C1C[C@@H](C(C)C)CC[C@@H]1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-BRWVUGGUSA-N 0.000 description 1
- 229960000698 nateglinide Drugs 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 230000006764 neuronal dysfunction Effects 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- JCZMXVGQBBATMY-UHFFFAOYSA-N nitro acetate Chemical compound CC(=O)O[N+]([O-])=O JCZMXVGQBBATMY-UHFFFAOYSA-N 0.000 description 1
- IQZPDFORWZTSKT-UHFFFAOYSA-N nitrosulphonic acid Chemical compound OS(=O)(=O)[N+]([O-])=O IQZPDFORWZTSKT-UHFFFAOYSA-N 0.000 description 1
- 125000005482 norpinyl group Chemical group 0.000 description 1
- 238000007344 nucleophilic reaction Methods 0.000 description 1
- VTRAEEWXHOVJFV-UHFFFAOYSA-N olmesartan Chemical compound CCCC1=NC(C(C)(C)O)=C(C(O)=O)N1CC1=CC=C(C=2C(=CC=CC=2)C=2NN=NN=2)C=C1 VTRAEEWXHOVJFV-UHFFFAOYSA-N 0.000 description 1
- 229960005117 olmesartan Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- PGODWLLZUZJNPW-KALLACGZSA-N oxaldehyde (1S,13R)-1,17,17-trimethyl-5,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene Chemical compound C(=O)C=O.C[C@]12CCN[C@H](CC3=C1C=C1C(=C3)N=CC=N1)C2(C)C PGODWLLZUZJNPW-KALLACGZSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachloro-phenol Natural products OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 1
- BEZDDPMMPIDMGJ-UHFFFAOYSA-N pentamethylbenzene Chemical compound CC1=CC(C)=C(C)C(C)=C1C BEZDDPMMPIDMGJ-UHFFFAOYSA-N 0.000 description 1
- 108091008765 peroxisome proliferator-activated receptors β/δ Proteins 0.000 description 1
- 150000004976 peroxydisulfates Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- PARWUHTVGZSQPD-UHFFFAOYSA-N phenylsilane Chemical compound [SiH3]C1=CC=CC=C1 PARWUHTVGZSQPD-UHFFFAOYSA-N 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 1
- 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 description 1
- 229960005095 pioglitazone Drugs 0.000 description 1
- 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920001843 polymethylhydrosiloxane Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- KCTFTBCZZUBAKN-UHFFFAOYSA-N pratosartan Chemical compound CCCC1=NC=2CCCCC(=O)C=2N1CC(C=C1)=CC=C1C1=CC=CC=C1C1=NN=NN1 KCTFTBCZZUBAKN-UHFFFAOYSA-N 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- HNDXKIMMSFCCFW-UHFFFAOYSA-N propane-2-sulphonic acid Chemical compound CC(C)S(O)(=O)=O HNDXKIMMSFCCFW-UHFFFAOYSA-N 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 125000004673 propylcarbonyl group Chemical group 0.000 description 1
- 239000003881 protein kinase C inhibitor Substances 0.000 description 1
- 125000002577 pseudohalo group Chemical group 0.000 description 1
- DVECLMOWYVDJRM-UHFFFAOYSA-N pyridine-3-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=CN=C1 DVECLMOWYVDJRM-UHFFFAOYSA-N 0.000 description 1
- 239000012048 reactive intermediate Substances 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- UAOCLDQAQNNEAX-ABMICEGHSA-N remogliflozin etabonate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)OCC)O[C@H]1OC1=NN(C(C)C)C(C)=C1CC1=CC=C(OC(C)C)C=C1 UAOCLDQAQNNEAX-ABMICEGHSA-N 0.000 description 1
- 229950011516 remogliflozin etabonate Drugs 0.000 description 1
- 229960002354 repaglinide Drugs 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 1
- 229960004586 rosiglitazone Drugs 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- QGJUIPDUBHWZPV-SGTAVMJGSA-N saxagliptin Chemical compound C1C(C2)CC(C3)CC2(O)CC13[C@H](N)C(=O)N1[C@H](C#N)C[C@@H]2C[C@@H]21 QGJUIPDUBHWZPV-SGTAVMJGSA-N 0.000 description 1
- 229960004937 saxagliptin Drugs 0.000 description 1
- 108010033693 saxagliptin Proteins 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 description 1
- 229960004425 sibutramine Drugs 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 150000003378 silver Chemical class 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 229960002855 simvastatin Drugs 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- MFFMDFFZMYYVKS-SECBINFHSA-N sitagliptin Chemical compound C([C@H](CC(=O)N1CC=2N(C(=NN=2)C(F)(F)F)CC1)N)C1=CC(F)=C(F)C=C1F MFFMDFFZMYYVKS-SECBINFHSA-N 0.000 description 1
- 229960004034 sitagliptin Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 229960001922 sodium perborate Drugs 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940035637 spectrum-4 Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 150000003459 sulfonic acid esters Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229940032330 sulfuric acid Drugs 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 125000006253 t-butylcarbonyl group Chemical group [H]C([H])([H])C(C(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003899 tartaric acid esters Chemical class 0.000 description 1
- 229960000651 tasosartan Drugs 0.000 description 1
- ADXGNEYLLLSOAR-UHFFFAOYSA-N tasosartan Chemical compound C12=NC(C)=NC(C)=C2CCC(=O)N1CC(C=C1)=CC=C1C1=CC=CC=C1C=1N=NNN=1 ADXGNEYLLLSOAR-UHFFFAOYSA-N 0.000 description 1
- 229960005187 telmisartan Drugs 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- DHRINWJGVOXSOG-MFJQRHCWSA-N tert-butyl (1R,9R)-1,13-dimethyl-4-(trifluoromethylsulfonyloxy)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C1C2=CC=C(OS(=O)(=O)C(F)(F)F)C=C2[C@]2(C)CCN(C(=O)OC(C)(C)C)[C@@]1([H])C2C DHRINWJGVOXSOG-MFJQRHCWSA-N 0.000 description 1
- DIUWGTLVSMHUBW-YXKFXFPPSA-N tert-butyl (1R,9R,13S)-4-cyano-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C1C2=CC=C(C#N)C=C2[C@]2(C)CCN(C(=O)OC(C)(C)C)[C@@]1([H])[C@H]2C DIUWGTLVSMHUBW-YXKFXFPPSA-N 0.000 description 1
- YGTICUOLWDVEOQ-SMNXXWJPSA-N tert-butyl (1R,9R,13S)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C1C2=CC=C(O)C=C2[C@]2(C)CCN(C(=O)OC(C)(C)C)[C@@]1([H])[C@H]2C YGTICUOLWDVEOQ-SMNXXWJPSA-N 0.000 description 1
- DDXBMIRCHRIPAJ-LAUBAEHRSA-N tert-butyl (1R,9S)-4-hydroxy-1,5,13,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C1C2=CC(C)=C(O)C=C2[C@@]2(C)CCN(C(=O)OC(C)(C)C)[C@]1([H])C2(C)C DDXBMIRCHRIPAJ-LAUBAEHRSA-N 0.000 description 1
- XGMDSNFMBNZRBL-LAUBAEHRSA-N tert-butyl (1R,9S)-5-hydroxy-1,4,13,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C1C2=CC(O)=C(C)C=C2[C@@]2(C)CCN(C(=O)OC(C)(C)C)[C@]1([H])C2(C)C XGMDSNFMBNZRBL-LAUBAEHRSA-N 0.000 description 1
- RMZQGZPAECCOKZ-UZLBHIALSA-N tert-butyl (1S,9R)-1,13,13-trimethyl-5-(trifluoromethylsulfonyloxy)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C1C2=CC(OS(=O)(=O)C(F)(F)F)=CC=C2[C@]2(C)CCN(C(=O)OC(C)(C)C)[C@@]1([H])C2(C)C RMZQGZPAECCOKZ-UZLBHIALSA-N 0.000 description 1
- WLINJTWGZDHZKV-UZLBHIALSA-N tert-butyl (1S,9R)-1,13,13-trimethyl-6-(trifluoromethylsulfonyloxy)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C12=CC=CC(OS(=O)(=O)C(F)(F)F)=C2C[C@H]2N(C(=O)OC(C)(C)C)CC[C@]1(C)C2(C)C WLINJTWGZDHZKV-UZLBHIALSA-N 0.000 description 1
- DDXBMIRCHRIPAJ-UTKZUKDTSA-N tert-butyl (1S,9R)-4-hydroxy-1,5,13,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C1C2=CC(C)=C(O)C=C2[C@]2(C)CCN(C(=O)OC(C)(C)C)[C@@]1([H])C2(C)C DDXBMIRCHRIPAJ-UTKZUKDTSA-N 0.000 description 1
- QXEXQUYGXHQOHK-UTKZUKDTSA-N tert-butyl (1S,9R)-5-cyano-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C1C2=CC(C#N)=CC=C2[C@]2(C)CCN(C(=O)OC(C)(C)C)[C@@]1([H])C2(C)C QXEXQUYGXHQOHK-UTKZUKDTSA-N 0.000 description 1
- ZDJUEPOAXZMYAO-UZLBHIALSA-N tert-butyl (1S,9R)-5-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C1C2=CC(O)=CC=C2[C@]2(C)CCN(C(=O)OC(C)(C)C)[C@@]1([H])C2(C)C ZDJUEPOAXZMYAO-UZLBHIALSA-N 0.000 description 1
- XGMDSNFMBNZRBL-UTKZUKDTSA-N tert-butyl (1S,9R)-5-hydroxy-1,4,13,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C1C2=CC(O)=C(C)C=C2[C@]2(C)CCN(C(=O)OC(C)(C)C)[C@@]1([H])C2(C)C XGMDSNFMBNZRBL-UTKZUKDTSA-N 0.000 description 1
- JXDVZAPUYCOTNE-UZLBHIALSA-N tert-butyl (1S,9R)-6-amino-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C12=CC=CC(N)=C2C[C@H]2N(C(=O)OC(C)(C)C)CC[C@]1(C)C2(C)C JXDVZAPUYCOTNE-UZLBHIALSA-N 0.000 description 1
- QVTLFSLFHSCBLJ-UZLBHIALSA-N tert-butyl (1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C12=CC=CC(O)=C2C[C@H]2N(C(=O)OC(C)(C)C)CC[C@]1(C)C2(C)C QVTLFSLFHSCBLJ-UZLBHIALSA-N 0.000 description 1
- FVUKBQDYIMTYII-UHFFFAOYSA-N tert-butyl 1,13,13-trimethyl-4-(trifluoromethylsulfonyloxy)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C12=CC(OS(=O)(=O)C(F)(F)F)=CC=C2CC2N(C(=O)OC(C)(C)C)CCC1(C)C2(C)C FVUKBQDYIMTYII-UHFFFAOYSA-N 0.000 description 1
- RMZQGZPAECCOKZ-UHFFFAOYSA-N tert-butyl 1,13,13-trimethyl-5-(trifluoromethylsulfonyloxy)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C12=CC=C(OS(=O)(=O)C(F)(F)F)C=C2CC2N(C(=O)OC(C)(C)C)CCC1(C)C2(C)C RMZQGZPAECCOKZ-UHFFFAOYSA-N 0.000 description 1
- UNYXRNUZCSNQSF-ZESTXYGFSA-N tert-butyl 2-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 UNYXRNUZCSNQSF-ZESTXYGFSA-N 0.000 description 1
- CIQVIYPBUZASRE-UHFFFAOYSA-N tert-butyl 4,5-dihydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene-10-carboxylate Chemical compound C12=CC(O)=C(O)C=C2CC2N(C(=O)OC(C)(C)C)CCC1(C)C2(C)C CIQVIYPBUZASRE-UHFFFAOYSA-N 0.000 description 1
- FRXGBJNCGGOKFW-UHFFFAOYSA-N tert-butyl 4,5-dimethoxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene-10-carboxylate Chemical compound C1C(C2(C)C)N(C(=O)OC(C)(C)C)CCC2(C)C2=C1C=C(OC)C(OC)=C2 FRXGBJNCGGOKFW-UHFFFAOYSA-N 0.000 description 1
- KXHAUFJDJWHHGN-UHFFFAOYSA-N tert-butyl 4-amino-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C12=CC(N)=CC=C2CC2N(C(=O)OC(C)(C)C)CCC1(C)C2(C)C KXHAUFJDJWHHGN-UHFFFAOYSA-N 0.000 description 1
- IUZQHKBKVZSGII-UHFFFAOYSA-N tert-butyl 4-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C12=CC(O)=CC=C2CC2N(C(=O)OC(C)(C)C)CCC1(C)C2(C)C IUZQHKBKVZSGII-UHFFFAOYSA-N 0.000 description 1
- CJRWAMMSDUQWGV-UHFFFAOYSA-N tert-butyl 4-hydroxy-5-methoxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene-10-carboxylate Chemical compound C1C(C2(C)C)N(C(=O)OC(C)(C)C)CCC2(C)C2=C1C=C(OC)C(O)=C2 CJRWAMMSDUQWGV-UHFFFAOYSA-N 0.000 description 1
- JGQTWXUPZNONKH-UHFFFAOYSA-N tert-butyl 5-amino-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C12=CC=C(N)C=C2CC2N(C(=O)OC(C)(C)C)CCC1(C)C2(C)C JGQTWXUPZNONKH-UHFFFAOYSA-N 0.000 description 1
- QXEXQUYGXHQOHK-UHFFFAOYSA-N tert-butyl 5-cyano-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carboxylate Chemical compound C12=CC=C(C#N)C=C2CC2N(C(=O)OC(C)(C)C)CCC1(C)C2(C)C QXEXQUYGXHQOHK-UHFFFAOYSA-N 0.000 description 1
- UZRCKGAIWRVOKA-WHHGMNPWSA-N tert-butyl N-[4-[(1S,9R)-6-hydroxy-1,13,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10-carbonyl]cyclohexyl]-N-methylcarbamate Chemical compound C1CC(N(C)C(=O)OC(C)(C)C)CCC1C(=O)N1[C@@H](C2(C)C)CC3=C(O)C=CC=C3[C@]2(C)CC1 UZRCKGAIWRVOKA-WHHGMNPWSA-N 0.000 description 1
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 1
- IOGXOCVLYRDXLW-UHFFFAOYSA-N tert-butyl nitrite Chemical compound CC(C)(C)ON=O IOGXOCVLYRDXLW-UHFFFAOYSA-N 0.000 description 1
- 239000012414 tert-butyl nitrite Substances 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- UNERIKIWOPRMDY-UHFFFAOYSA-N tetradeca-2,4,6-triene Chemical compound CCCCCCCC=CC=CC=CC UNERIKIWOPRMDY-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000001467 thiazolidinediones Chemical class 0.000 description 1
- HNKJADCVZUBCPG-UHFFFAOYSA-N thioanisole Chemical compound CSC1=CC=CC=C1 HNKJADCVZUBCPG-UHFFFAOYSA-N 0.000 description 1
- BSXLLFUSNQCWJP-UHFFFAOYSA-N thiophene-2-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=CS1 BSXLLFUSNQCWJP-UHFFFAOYSA-N 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 229960005371 tolbutamide Drugs 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- TUQOTMZNTHZOKS-UHFFFAOYSA-N tributylphosphine Chemical compound CCCCP(CCCC)CCCC TUQOTMZNTHZOKS-UHFFFAOYSA-N 0.000 description 1
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 1
- FAQYAMRNWDIXMY-UHFFFAOYSA-N trichloroborane Chemical compound ClB(Cl)Cl FAQYAMRNWDIXMY-UHFFFAOYSA-N 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 1
- AHZJKOKFZJYCLG-UHFFFAOYSA-K trifluoromethanesulfonate;ytterbium(3+) Chemical compound [Yb+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F AHZJKOKFZJYCLG-UHFFFAOYSA-K 0.000 description 1
- MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 1
- 125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 description 1
- SEDZOYHHAIAQIW-UHFFFAOYSA-N trimethylsilyl azide Chemical compound C[Si](C)(C)N=[N+]=[N-] SEDZOYHHAIAQIW-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- COIOYMYWGDAQPM-UHFFFAOYSA-N tris(2-methylphenyl)phosphane Chemical compound CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C COIOYMYWGDAQPM-UHFFFAOYSA-N 0.000 description 1
- DLQYXUGCCKQSRJ-UHFFFAOYSA-N tris(furan-2-yl)phosphane Chemical compound C1=COC(P(C=2OC=CC=2)C=2OC=CC=2)=C1 DLQYXUGCCKQSRJ-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000003424 uricosuric effect Effects 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
- ACWBQPMHZXGDFX-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=NN1 ACWBQPMHZXGDFX-QFIPXVFZSA-N 0.000 description 1
- 229960004699 valsartan Drugs 0.000 description 1
- SYOKIDBDQMKNDQ-XWTIBIIYSA-N vildagliptin Chemical compound C1C(O)(C2)CC(C3)CC1CC32NCC(=O)N1CCC[C@H]1C#N SYOKIDBDQMKNDQ-XWTIBIIYSA-N 0.000 description 1
- 229960001254 vildagliptin Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229960001729 voglibose Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- GTLDTDOJJJZVBW-UHFFFAOYSA-N zinc cyanide Chemical compound [Zn+2].N#[C-].N#[C-] GTLDTDOJJJZVBW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/26—Benzomorphans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/18—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08156122.7 | 2008-05-13 | ||
| EP08156122 | 2008-05-13 | ||
| PCT/EP2009/055687 WO2009138386A2 (en) | 2008-05-13 | 2009-05-12 | Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2724214A1 true CA2724214A1 (en) | 2009-11-19 |
Family
ID=41319098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2724214A Abandoned CA2724214A1 (en) | 2008-05-13 | 2009-05-12 | Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8765780B2 (enExample) |
| EP (1) | EP2288596B1 (enExample) |
| JP (1) | JP5711115B2 (enExample) |
| AR (1) | AR071719A1 (enExample) |
| CA (1) | CA2724214A1 (enExample) |
| CL (1) | CL2009001151A1 (enExample) |
| TW (1) | TW200950780A (enExample) |
| WO (1) | WO2009138386A2 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2125750B1 (en) | 2007-02-26 | 2014-05-21 | Vitae Pharmaceuticals, Inc. | Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| WO2009017671A1 (en) | 2007-07-26 | 2009-02-05 | Vitae Pharmaceuticals, Inc. | Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| AR069207A1 (es) | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 |
| EP2220048B1 (en) * | 2007-11-16 | 2017-01-25 | Boehringer Ingelheim International GmbH | Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| US8440658B2 (en) | 2007-12-11 | 2013-05-14 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| TW200934490A (en) | 2008-01-07 | 2009-08-16 | Vitae Pharmaceuticals Inc | Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1 |
| US8592409B2 (en) | 2008-01-24 | 2013-11-26 | Vitae Pharmaceuticals, Inc. | Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| EP2245014B1 (en) * | 2008-02-12 | 2011-11-02 | Boehringer Ingelheim International GmbH | Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| CA2715290A1 (en) | 2008-02-15 | 2009-08-20 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| WO2009117109A1 (en) * | 2008-03-18 | 2009-09-24 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| JP5301563B2 (ja) | 2008-05-01 | 2013-09-25 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター |
| EP2291371B1 (en) | 2008-05-01 | 2015-06-10 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| CA2723034A1 (en) | 2008-05-01 | 2009-11-05 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| EP2288596B1 (en) | 2008-05-13 | 2016-11-30 | Boehringer Ingelheim International GmbH | Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use |
| CA2729998A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| PL2324018T3 (pl) | 2008-07-25 | 2014-02-28 | Boehringer Ingelheim Int | Cykliczne inhibitory dehydrogenazy 11 beta-hydroksysteroidowej typu 1 |
| US8273900B2 (en) | 2008-08-07 | 2012-09-25 | Novartis Ag | Organic compounds |
| WO2010046445A2 (en) | 2008-10-23 | 2010-04-29 | Boehringer Ingelheim International Gmbh | Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use |
| JP5679997B2 (ja) | 2009-02-04 | 2015-03-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤 |
| MA33216B1 (fr) | 2009-04-30 | 2012-04-02 | Boehringer Ingelheim Int | Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1 |
| WO2010139673A1 (en) | 2009-06-02 | 2010-12-09 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| WO2011011123A1 (en) | 2009-06-11 | 2011-01-27 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| EP2448928B1 (en) | 2009-07-01 | 2014-08-13 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8933072B2 (en) | 2010-06-16 | 2015-01-13 | Vitae Pharmaceuticals, Inc. | Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| EP2585444B1 (en) | 2010-06-25 | 2014-10-22 | Boehringer Ingelheim International GmbH | Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| WO2012059416A1 (en) | 2010-11-02 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations for the treatment of metabolic disorders |
| EP2744783A1 (en) | 2011-08-17 | 2014-06-25 | Boehringer Ingelheim International GmbH | Indenopyridine derivatives |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| CN104125960A (zh) | 2011-12-22 | 2014-10-29 | 康内克斯生命科学私人有限公司 | 氮杂金刚烷的衍生物及其用途 |
| CN102827056B (zh) * | 2012-09-03 | 2014-07-23 | 华东理工大学 | N-芳基取代吡咯烷酮衍生物及其用途 |
| CA2917527C (en) * | 2013-07-15 | 2022-06-14 | Board Of Regents, The University Of Texas System | Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain |
| WO2015100174A1 (en) * | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | Ring-contracted morphinans and the use thereof |
| US11046670B2 (en) | 2015-10-19 | 2021-06-29 | Board Of Regents, The University Of Texas System | Piperazinyl norbenzomorphan compounds and methods for using the same |
| US10954217B2 (en) | 2016-04-29 | 2021-03-23 | Board Of Regents, The University Of Texas System | Sigma receptor binders |
| WO2021210014A1 (en) * | 2020-04-14 | 2021-10-21 | Shiv Nadar University | Therapeutic novel chemical entities and method thereof |
| WO2025032129A1 (en) | 2023-08-08 | 2025-02-13 | Syngenta Crop Protection Ag | Novel aminoindane and aminotetraline compounds |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3378587A (en) | 1963-03-14 | 1968-04-16 | Du Pont | 3, 3'-diaminomethyl-1, 1'-biadamantane |
| NL127995C (enExample) | 1963-12-20 | Geigy Ag J R | ||
| US3341538A (en) | 1965-06-18 | 1967-09-12 | Geigy Chem Corp | Certain 2, 6-methano-3-benzazocines |
| US3474106A (en) | 1966-11-16 | 1969-10-21 | Hoffmann La Roche | 3-lower-alkyl - 1,2,3,4,5,6 - hexahydro-6,11-di-lower-alkyl - 9-diethylaminomethyl-2,6-methano-3-benzazocin-8-ols |
| US3539637A (en) * | 1967-04-10 | 1970-11-10 | Geigy Chem Corp | N-carbamyl and thiocarbamyl-2,3,4,5-tetrahydro - 1,4 - methano - 1h - 3-benzazepines |
| DE2108954A1 (en) | 1971-02-25 | 1972-09-07 | Boehringer Sohn Ingelheim | 2-(furylmethyl)-6,7-benzomorphans - useful as cns active agents |
| GB1304175A (enExample) | 1969-03-31 | 1973-01-24 | ||
| DE2105743C3 (de) | 1971-02-08 | 1979-11-29 | Boehringer Sohn Ingelheim | 2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung |
| CS166801B2 (enExample) | 1971-02-08 | 1976-03-29 | Boehringer Sohn Ingelheim | |
| US4043927A (en) | 1972-03-07 | 1977-08-23 | Sun Ventures, Inc. | Friction or tractive drive containing ethers of adamantanes |
| US3856795A (en) | 1972-04-25 | 1974-12-24 | American Home Prod | Process for preparation of secondary amines from tertiary amines |
| DE2229695A1 (de) | 1972-06-19 | 1974-01-31 | Boehringer Sohn Ingelheim | 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung |
| DE2338369A1 (de) | 1973-07-26 | 1975-02-13 | Schering Ag | Mikrobiologische hydroxylierung von 2,6-methano-3-benzazocinen |
| SU511005A3 (ru) | 1973-10-27 | 1976-04-15 | К.Х.Берингер Зон., (Фирма) | Способ получени (метоксиметилфурилметил)6,7-бензоморфанов или морфинанов |
| US4009171A (en) | 1974-02-21 | 1977-02-22 | Sterling Drug Inc. | N-acylated-11-oxygenated-2,6-methano-3-benzazocine intermediates |
| DE2411382C3 (de) | 1974-03-09 | 1979-09-06 | C.H. Boehringer Sohn, 6507 Ingelheim | 2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung |
| DE2437610A1 (de) | 1974-08-05 | 1976-02-26 | Boehringer Sohn Ingelheim | Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung |
| GB1513961A (en) | 1975-02-25 | 1978-06-14 | Acf Chemiefarma Nv | 6,7-benzomorphans method for their preparation and intermediates |
| US4108857A (en) | 1975-08-18 | 1978-08-22 | Sterling Drug Inc. | Imidazolylmethyl methanobenzazocines |
| JPS5919542B2 (ja) | 1976-06-24 | 1984-05-07 | 旭電化工業株式会社 | ベンズアゾシン誘導体 |
| DE2828039A1 (de) | 1978-06-26 | 1980-01-10 | Boehringer Sohn Ingelheim | 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung |
| US5607941A (en) | 1992-06-26 | 1997-03-04 | Boehringer Ingelheim Kg | Useful for treating neurodegenerative diseases |
| US5354758A (en) | 1992-12-16 | 1994-10-11 | Japan Tobacco Inc. | Benzomorphans useful as NMDA receptor antagonists |
| GB9510459D0 (en) | 1995-05-24 | 1995-07-19 | Zeneca Ltd | Bicyclic amines |
| GB9517622D0 (en) | 1995-08-29 | 1995-11-01 | Univ Edinburgh | Regulation of intracellular glucocorticoid concentrations |
| GB9623944D0 (en) | 1996-11-15 | 1997-01-08 | Zeneca Ltd | Bicyclic amine derivatives |
| NZ501112A (en) | 1997-05-22 | 2002-10-25 | G | Substituted pyrazoles as p38 kinase inhibitors |
| US6145103A (en) | 1998-04-07 | 2000-11-07 | Advanced Micro Devices, Inc. | Emulator support mode for disabling and reconfiguring timeouts of a watchdog timer |
| FR2796940B1 (fr) | 1999-07-26 | 2005-04-08 | Lipha | Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant |
| WO2001055063A1 (en) | 2000-01-25 | 2001-08-02 | Idemitsu Petrochemical Co., Ltd. | Novel bisadamantane compounds, process for preparing the same, and novel biadamantane derivatives |
| DE10034623A1 (de) | 2000-07-17 | 2002-01-31 | Bayer Ag | Heterocyclisch substituierte Pyridine als Cytokin-Inhibitoren |
| JP2003057815A (ja) | 2001-06-05 | 2003-02-28 | Sumitomo Chem Co Ltd | 化学増幅型レジスト組成物 |
| MXPA04011327A (es) | 2002-05-17 | 2005-08-15 | Jenken Biosciences Inc | Opioides y compuestos similares a opioides y usos de los mismos. |
| US7276520B2 (en) | 2003-03-26 | 2007-10-02 | Merck & Co., Inc. | Bicyclic piperidine derivatives as melanocortin-4 receptor agonists |
| JP4629657B2 (ja) | 2003-04-11 | 2011-02-09 | ハイ・ポイント・ファーマスーティカルズ、エルエルシー | １１β−ヒドロキシステロイドデヒドロゲナーゼ１型化活性化合物 |
| US7700583B2 (en) | 2003-04-11 | 2010-04-20 | High Point Pharmaceuticals, Llc | 11β-hydroxysteroid dehydrogenase type 1 active compounds |
| JP2007015930A (ja) | 2004-09-13 | 2007-01-25 | Ono Pharmaceut Co Ltd | 複素ビシクロ環および複素トリシクロ環化合物およびその医薬 |
| MXPA06012932A (es) | 2004-05-07 | 2007-01-26 | Janssen Pharmaceutica Nv | Derivados de pirrolidin-2-ona y piperidin-2-ona como inhibidores de 11-beta hidroxiesteroide deshidrogenasa. |
| WO2005108361A1 (en) | 2004-05-07 | 2005-11-17 | Janssen Pharmaceutica N.V. | Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| KR101197672B1 (ko) | 2004-08-30 | 2012-11-07 | 얀센 파마슈티카 엔.브이. | 11-베타 하이드록시스테로이드 데하이드로게나제저해제로서 트리사이클릭 락탐 유도체 |
| JP2008515956A (ja) | 2004-10-12 | 2008-05-15 | ノボ ノルディスク アクティーゼルスカブ | １１β−ヒドロキシステロイドデヒドロゲナーゼ１型活性スピロ化合物 |
| CA2581745A1 (en) | 2004-10-13 | 2006-04-27 | Neurogen Corporation | Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor |
| US20090264650A1 (en) | 2005-03-31 | 2009-10-22 | Nobuo Cho | Prophylactic/Therapeutic Agent for Diabetes |
| JP4935196B2 (ja) | 2005-06-08 | 2012-05-23 | 住友ベークライト株式会社 | ベンゾオキサゾール前駆体、樹脂組成物およびそれを用いたコーティングワニス、樹脂膜並びに半導体装置 |
| JP4815883B2 (ja) | 2005-06-08 | 2011-11-16 | 住友ベークライト株式会社 | ビアダマンタン誘導体 |
| JP2009514818A (ja) | 2005-11-01 | 2009-04-09 | ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー | 置換アミドの製薬学的用途 |
| JP2007140188A (ja) | 2005-11-18 | 2007-06-07 | Fujifilm Corp | ポジ型感光性組成物及びそれを用いたパターン形成方法 |
| WO2007076055A2 (en) | 2005-12-22 | 2007-07-05 | Entremed, Inc. | Compositions and methods comprising proteinase activated receptor antagonists |
| WO2007081570A2 (en) | 2005-12-30 | 2007-07-19 | Merck & Co., Inc. | Cholesteryl ester transfer protein inhibitors |
| JP2007254409A (ja) | 2006-03-24 | 2007-10-04 | Taisho Pharmaceut Co Ltd | イミダゾリジノン誘導体 |
| JP2007269721A (ja) | 2006-03-31 | 2007-10-18 | Daicel Chem Ind Ltd | ビアダマンタンカルボン酸誘導体の製造法 |
| WO2007124337A1 (en) | 2006-04-21 | 2007-11-01 | Eli Lilly And Company | Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| JP5189078B2 (ja) | 2006-04-24 | 2013-04-24 | イーライ リリー アンド カンパニー | １１−β−ヒドロキシステロイドデヒドロゲナーゼ１の阻害剤 |
| US7968585B2 (en) | 2006-04-25 | 2011-06-28 | Eli Lilly And Company | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| PE20080344A1 (es) | 2006-06-27 | 2008-06-09 | Sanofi Aventis | Compuestos 8-azabiciclo[3.2.1]oct-8-il-1,2,3,4-tetrahidroquinolina sustituidos como inhibidores 11b-hsd1 |
| TW200829171A (en) | 2006-11-17 | 2008-07-16 | Nihon Nohyaku Co Ltd | Haloalkyl sulfonanilide derivatives or salts thereof, herbicide using it as effective constituent and use-method thereof |
| EP1935420A1 (en) | 2006-12-21 | 2008-06-25 | Merck Sante | 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
| EP2125750B1 (en) | 2007-02-26 | 2014-05-21 | Vitae Pharmaceuticals, Inc. | Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| WO2009017671A1 (en) | 2007-07-26 | 2009-02-05 | Vitae Pharmaceuticals, Inc. | Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| AR069207A1 (es) | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 |
| EP2220048B1 (en) * | 2007-11-16 | 2017-01-25 | Boehringer Ingelheim International GmbH | Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| JP5734666B2 (ja) | 2008-02-11 | 2015-06-17 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | １１β−ヒドロキシステロイドデヒドロゲナーゼ１の１，３−オキサアゼパン−２−オン及び１，３−ジアゼパン−２−オン阻害剤 |
| EP2245014B1 (en) | 2008-02-12 | 2011-11-02 | Boehringer Ingelheim International GmbH | Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| CA2715290A1 (en) | 2008-02-15 | 2009-08-20 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| WO2009117109A1 (en) | 2008-03-18 | 2009-09-24 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| TW200944526A (en) | 2008-04-22 | 2009-11-01 | Vitae Pharmaceuticals Inc | Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| CA2723034A1 (en) | 2008-05-01 | 2009-11-05 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| JP5301563B2 (ja) | 2008-05-01 | 2013-09-25 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター |
| EP2288596B1 (en) | 2008-05-13 | 2016-11-30 | Boehringer Ingelheim International GmbH | Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use |
| CA2729998A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| PL2324018T3 (pl) | 2008-07-25 | 2014-02-28 | Boehringer Ingelheim Int | Cykliczne inhibitory dehydrogenazy 11 beta-hydroksysteroidowej typu 1 |
| WO2010010174A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use |
| US8609690B2 (en) | 2008-08-25 | 2013-12-17 | Boehringer Ingelheim International Gmbh | Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use |
| WO2010046445A2 (en) | 2008-10-23 | 2010-04-29 | Boehringer Ingelheim International Gmbh | Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use |
| MA33216B1 (fr) | 2009-04-30 | 2012-04-02 | Boehringer Ingelheim Int | Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1 |
| WO2010139673A1 (en) | 2009-06-02 | 2010-12-09 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| UY33001A (es) | 2009-11-06 | 2011-05-31 | Boehringer Ingelheim Int | Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina |
| TWI537258B (zh) | 2010-11-05 | 2016-06-11 | 百靈佳殷格翰國際股份有限公司 | 六氫茚并吡啶及八氫苯并喹啉之芳基－及雜環芳基羰基衍生物 |
| EP2744783A1 (en) | 2011-08-17 | 2014-06-25 | Boehringer Ingelheim International GmbH | Indenopyridine derivatives |
-
2009
- 2009-05-12 EP EP09745718.8A patent/EP2288596B1/en active Active
- 2009-05-12 CL CL2009001151A patent/CL2009001151A1/es unknown
- 2009-05-12 TW TW098115741A patent/TW200950780A/zh unknown
- 2009-05-12 WO PCT/EP2009/055687 patent/WO2009138386A2/en not_active Ceased
- 2009-05-12 AR ARP090101711A patent/AR071719A1/es unknown
- 2009-05-12 US US12/991,722 patent/US8765780B2/en active Active
- 2009-05-12 JP JP2011508887A patent/JP5711115B2/ja active Active
- 2009-05-12 CA CA2724214A patent/CA2724214A1/en not_active Abandoned
-
2014
- 2014-02-27 US US14/191,951 patent/US9073870B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011520832A (ja) | 2011-07-21 |
| AR071719A1 (es) | 2010-07-07 |
| CL2009001151A1 (es) | 2010-08-13 |
| US9073870B2 (en) | 2015-07-07 |
| EP2288596A2 (en) | 2011-03-02 |
| US20140179669A1 (en) | 2014-06-26 |
| EP2288596B1 (en) | 2016-11-30 |
| JP5711115B2 (ja) | 2015-04-30 |
| TW200950780A (en) | 2009-12-16 |
| US20110269791A1 (en) | 2011-11-03 |
| WO2009138386A3 (en) | 2010-02-11 |
| WO2009138386A2 (en) | 2009-11-19 |
| US8765780B2 (en) | 2014-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2724214A1 (en) | Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use | |
| EP2220048B1 (en) | Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use | |
| CA2711757C (en) | Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use | |
| CA2735204C (en) | Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use | |
| CA2738453C (en) | Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use | |
| EP2496559B1 (en) | Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline and their use as hsd 1 inhibitors | |
| US8686149B2 (en) | Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline | |
| OA16399A (en) | Crystalline forms of hydrochloride salt of (4AR, 9A-S)-1-(1H-benzoimidazole-5-car-bonyl)-2, 3, 4, 4A 9, 9A-hexahydro-1H-indeno[2, 1-B] pyridine6-carbonitrile and their use as HSD 1 inhibitors. | |
| OA16619A (en) | Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydro benzoquinoline. | |
| HK1187334A (en) | Benzodioxane inhibitors of leukotriene production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20140509 |
|
| FZDE | Dead |
Effective date: 20171201 |